Global Point of Care (POC) Diagnostic Devices Market By Product Type (Albumin Analyzers (Albumin Testing), Blood Lactate Analyzer / Blood Lactate Testing Equipment, Cardiac Marker Analyzers, Clinical Chemistry Analyzers, Coagulation Analyzer / Microcoagulation System, Creatinine Analyzer, CRP Analyzer (C-Reactive Protein Analyzers), Laboratory Blood Glucose Analyzers, Urinalysis Products (Analyzers, Strips, Controls, Supplies), Drugs-of-abuse Testing Products, Fecal Occult Testing Products, Hematology Testing Products, HbA1c and Diabetes Products, Infectious Disease Testing Products (HIV Infections, Malaria, Syphilis, E.Coli, Influenza, Others), Others (CO-Oximeter, etc.)); By Formats (Dipstick and Lateral Flow Configurations, Microfluidics, Magnetic immunoassay, Molecular Diagnostics); By Device Type (Handheld, Benchtop models); By Type (Prescription based, Over the counter (OTC)); By End Users (Hospitals (Critical Care Units, Neonatal Intensive Care Unit (NICU), Others), Private clinics, Diagnostic centres, Home Care Settings, Doctor’s Offices, Ambulatory Care Centers, Emergency Departments, Laboratories, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
- Industry Trends
The growing prevalence of chronic illnesses amongst the global population is driving the demand for rapid, near-patient diagnostics devices which will enhance the care delivery to patients.
Chronic illnesses are witnessing an upsurge in the number of people affected due to the sedentary lifestyle and degrading quality of human ecosystems. World Health Organization states that chronic non-communicable diseases are the reason for 70% of deaths worldwide. Diabetes is one of the most common chronic non-communicable disease which caused death of 1.6 million people across the globe being the seventh leading cause of deaths in 2016. Patients with Type 2 diabetes require frequent glucose monitoring to control the insulin administration levels, which has created high demand for rapid point of care (POC) diagnostic devices. The POC diagnostic devices can be termed as solutions that provide rapid actionable information for patient care at the time and site of an encounter with the health care system. These devices encompasses any tools which perform tests at or near a patient and at the site where care or treatment is provided. Results of POC diagnostic devices are typically available relatively quickly so that they can be acted upon without delay. POC diagnostic devices have proved their mettle in effectively managing diabetes, thus witnessing high demand from the growing diabetic population across the world. For instance, 1mg, an online pharmacy store, witnessed a spike of 90% in the demand of glucometers (POC diagnostic device for monitoring blood sugar levels) in May 2020. Attempts are also being made to incorporate advanced digital technologies in the traditional POC diagnostic devices to increase their speed and accuracy. Artificial Intelligence algorithms are being incorporated in these devices to make them more easy to use and highly effective. The American Academy of Ophthalmology recommends that patients with Type 1 diabetes should be undergone diabetic retinopathy screening within 5 years of diabetes onset and then annually after 10 years duration. Companies have developed deep learning algorithms which performs automated analysis of fundus photos for POC diabetic retinopathy diagnosis to prevent blindness. For instance, Eyenuk developed deep learning based system called EyeArt for diabetic retinopathy screening at POC locations and received clearance from U.S Food and Drug Administration agency in August 2020. In similar instance, Singapore Eye Research Institute (SERI) has validated the SERI-NUS DL system and Google has validated Google Deep Mind convolutional neural network for diabetic retinopathy detection. Thus, the high prevalence of chronic illnesses coupled with incorporation of advanced technologies is driving the growth of global point of care (POC) diagnostic devices market.
The growing penetration of counterfeit products in the medical supply chains is impacting the growth of market. World Health Organization estimates that up to 8% of the medical devices in circulation are counterfeit. The false diagnosis of these products leads to improper treatment and increasing burden of health costs. To overcome these challenges, companies are developing advanced security solutions. For instance, IBM Corporation presented a novel optical security code solution at Biosensors 2018 conference. This technology encompasses creation of optical security codes by inkjet spotting patterns which can be used in combination with smartphones for authenticating medical test kits. Holograms are another potential solution for tackling the challenges of counterfeit products as they are can be easily printed and incur low costs. Application of these solutions for overcoming the hindrances posed by counterfeiting is anticipated to propel the growth of global point of care (POC) diagnostic devices market in coming years.
The recent outbreak of COVID-19 pandemic has inflated the number of tests performed to identify the infection, thus, creating burden on existing hospitals, clinics and laboratories. This has led to the development of POC testing devices for performing rapid tests on the field itself. In June 2020, a researcher from Indian Institute of Technology, Hyderabad developed an Artificial Intelligence-powered POC test kit for COVID-19, which can perform diagnosis at an affordable cost. This test kit can produce results in around 20 minutes for symptomatic and asymptomatic patients. In Similar instance, U.S Food and Drug Administration agency approved Cepheid's POC diagnostic test kit, which can diagnose COVID-19 in 45 minutes. The coronavirus crisis has also transformed the health care requirements and expectations of patients creating a high inclination towards telehealth services. This trend is attracting market players to launch POC diagnostic devices designed for telehealth platforms. For instance, Luminostics, Inc. partnered with Sanofi in April 2020 for developing a 15-minutes Smartphone-based point-of-care test for SARS-CoV-2 infection from respiratory samples. The POC diagnostics device of this company will be compatible with most of the smartphones and can detect or measure bacteria, viruses, proteins and hormones from swabs, saliva, urine or blood. The software of this POC device, after analysing the results of test, connects the user to telehealth platform. Thus, the increasing number of tests and growing adoption of on-demand healthcare services amidst COVID-19 outbreak is anticipated to fuel the growth of global point of care (POC) diagnostic devices market.
Product Type Outlook:
The infectious disease testing products are witnessing high growth in the global point of care (POC) diagnostic devices market owing to the growing need for diagnosis of infectious diseases like HIV, dengue fever, malaria, influenza and others. Infectious disease tests performed at the POC in community clinics and remote or resource-limited areas can lead to faster delivery of treatment, which can prevent infections from spreading further. This requirement has encouraged biotechnology companies to develop advanced POC diagnostic devices that enables a rapid diagnosis of infection. For instance, Inflammatix, Inc. received a funding of US$ 32 million and a contract from U.S. Biomedical Advanced Research and Development Authority (BARDA) in January 2020 to develop novel POC infection diagnostic kits. Thus, the rising number of patients with infectious diseases and the on-going development of advanced test kits is propelling the share of infectious disease testing products in the global point of care (POC) diagnostic devices market.
Format Outlook:
Molecular POC diagnostics are polymerase chain reaction based tests which have a high sensitivity and accuracy compared to other tests which contributes towards its popularity. Recently, nucleic acid-based molecular diagnostics technologies are emerging which further enhances the speed of tests, lowers the cost and makes the diagnostic devices easy to use. For instance, the be.well system of Alveo Technology incorporates nucleic acid detection and is connected to the cloud to provide inputs on 100 infectious diseases. Molecular POC diagnostic devices are also witnessing high demand amidst COVID-19 pandemic. Major biotech companies such as Abbott Point of Care Inc., GenMark Diagnostics, Inc., Credo Diagnostics Biomedical Pte. Ltd. and others have developed molecular POC diagnostic devices for detecting COVID-19. These factors are propelling the growth of molecular diagnostics in global point of care (POC) diagnostic devices market.
Regional Outlook:
North America region registered the highest share in global point of care (POC) diagnostic devices market in 2018. The growing geriatric population in the region which increases the prevalence of chronic ailments is a major factor contributing towards high share of North America. However, the low and middle-income countries from Asia Pacific region are witnessing rise in demand for medical services driven by the growing number of sick people due to high tobacco use, physical inactivity, the harmful use of alcohol and unhealthy diets. Also, governments of countries such as Malaysia, China, India, Japan and others are promoting use of POC diagnostic devices by releasing guidelines for proper implementation. These factors are anticipated to propel the share of Asia Pacific region in global point of care (POC) diagnostic devices market over forecast period.
In terms of revenue, global point of care (POC) diagnostic devices market is anticipated to grow at a CAGR of 9.1% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Esports Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of point of care (POC) diagnostic devices market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the point of care (POC) diagnostic devices market are Abbott Point of Care Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher, DIADAMA MEDICAL SL, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Nova Biomedical, Siemens Healthcare Limited and Sysmex Corporation amongst others.
Global Point of Care (POC) Diagnostic Devices Market:
By Product Type
- Albumin Analyzers (Albumin Testing)
- Blood Lactate Analyzer / Blood Lactate Testing Equipment
- Cardiac Marker Analyzers
- Clinical Chemistry Analyzers
- Coagulation Analyzer / Microcoagulation System
- Creatinine Analyzer
- CRP Analyzer (C-Reactive Protein Analyzers)
- Laboratory Blood Glucose Analyzers
- Urinalysis Products
- Analyzers
- Strips
- Controls
- Supplies
- Drugs-of-abuse Testing Products
- Fecal Occult Testing Products
- Hematology Testing Products
- HbA1c and Diabetes Products
- Infectious Disease Testing Products
- HIV Infections
- Malaria
- Syphilis
- E.Coli
- Influenza
- Others
- Others (CO-Oximeter, etc.)
By Formats
- Dipstick and Lateral Flow Configurations
- Microfluidics
- Magnetic immunoassay
- Molecular Diagnostics
By Device Type
- Handheld
- Benchtop models
By Type
- Prescription based
- Over the counter (OTC)
By End Users:
- Hospitals
- Critical Care Units
- Neonatal Intensive Care Unit (NICU)
- Others
- Private clinics
- Diagnostic centres
- Home Care Settings
- Doctor’s Offices
- Ambulatory Care Centers
- Emergency Departments
- Laboratories
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Point of Care (POC) Diagnostic Devices
Market
6. Market Synopsis: Point
of Care (POC) Diagnostic Devices Market
7. Point of Care (POC) Diagnostic Devices Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Point of Care (POC) Diagnostic Devices Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Point of Care (POC) Diagnostic Devices Market
7.6. Porter’s
Five Force Analysis
8. Global Point of Care (POC) Diagnostic Devices Market Analysis
and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
8.2. Global
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
8.2.1. Albumin
Analyzers (Albumin Testing)
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.2.3. Cardiac
Marker Analyzers
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.2.4. Clinical
Chemistry Analyzers
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2018
8.2.4.3. Market
Forecast, 2019 – 2027
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2018
8.2.4.5.1.2. Market
Forecast, 2019 – 2027
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2018
8.2.4.5.2.2. Market
Forecast, 2019 – 2027
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2018
8.2.4.5.3.2. Market
Forecast, 2019 – 2027
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2018
8.2.4.5.4.2. Market
Forecast, 2019 – 2027
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2018
8.2.4.5.5.2. Market
Forecast, 2019 – 2027
8.2.5. Coagulation
Analyzer / Microcoagulation System
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2018
8.2.5.3. Market
Forecast, 2019 – 2027
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2018
8.2.5.5.1.2. Market
Forecast, 2019 – 2027
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2018
8.2.5.5.2.2. Market
Forecast, 2019 – 2027
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2018
8.2.5.5.3.2. Market
Forecast, 2019 – 2027
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2018
8.2.5.5.4.2. Market
Forecast, 2019 – 2027
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2018
8.2.5.5.5.2. Market
Forecast, 2019 – 2027
8.2.6. Creatinine
Analyzer
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 – 2018
8.2.6.3. Market
Forecast, 2019 – 2027
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2015 – 2018
8.2.6.5.1.2. Market
Forecast, 2019 – 2027
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 – 2018
8.2.6.5.2.2. Market
Forecast, 2019 – 2027
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2015 – 2018
8.2.6.5.3.2. Market
Forecast, 2019 – 2027
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 – 2018
8.2.6.5.4.2. Market
Forecast, 2019 – 2027
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2015 – 2018
8.2.6.5.5.2. Market
Forecast, 2019 – 2027
8.2.7. CRP
Analyzer (C-Reactive Protein Analyzers)
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 – 2018
8.2.7.3. Market
Forecast, 2019 – 2027
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 – 2018
8.2.7.5.1.2. Market
Forecast, 2019 – 2027
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 – 2018
8.2.7.5.2.2. Market
Forecast, 2019 – 2027
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 – 2018
8.2.7.5.3.2. Market
Forecast, 2019 – 2027
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 – 2018
8.2.7.5.4.2. Market
Forecast, 2019 – 2027
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 – 2018
8.2.7.5.5.2. Market
Forecast, 2019 – 2027
8.2.8. Laboratory
Blood Glucose Analyzers
8.2.8.1. Definition
8.2.8.2. Market
Estimation and Penetration, 2015 – 2018
8.2.8.3. Market
Forecast, 2019 – 2027
8.2.8.4. Compound
Annual Growth Rate (CAGR)
8.2.8.5. Regional
Bifurcation
8.2.8.5.1. North
America
8.2.8.5.1.1. Market
Estimation, 2015 – 2018
8.2.8.5.1.2. Market
Forecast, 2019 – 2027
8.2.8.5.2. Europe
8.2.8.5.2.1. Market
Estimation, 2015 – 2018
8.2.8.5.2.2. Market
Forecast, 2019 – 2027
8.2.8.5.3. Asia
Pacific
8.2.8.5.3.1. Market
Estimation, 2015 – 2018
8.2.8.5.3.2. Market
Forecast, 2019 – 2027
8.2.8.5.4. Middle
East and Africa
8.2.8.5.4.1. Market
Estimation, 2015 – 2018
8.2.8.5.4.2. Market
Forecast, 2019 – 2027
8.2.8.5.5. Latin
America
8.2.8.5.5.1. Market
Estimation, 2015 – 2018
8.2.8.5.5.2. Market
Forecast, 2019 – 2027
8.2.9. Urinalysis
Products (Definition, Market Estimation and Penetration, 2015 – 2018, Market
Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Analyzers, Strips, Controls,
Supplies)
8.2.9.1. Analyzers
8.2.9.2. Strips
8.2.9.3. Controls
8.2.9.4. Supplies
8.2.10. Drugs-of-abuse
Testing Products
8.2.10.1. Definition
8.2.10.2. Market
Estimation and Penetration, 2015 – 2018
8.2.10.3. Market
Forecast, 2019 – 2027
8.2.10.4. Compound
Annual Growth Rate (CAGR)
8.2.10.5. Regional
Bifurcation
8.2.10.5.1. North
America
8.2.10.5.1.1. Market
Estimation, 2015 – 2018
8.2.10.5.1.2. Market
Forecast, 2019 – 2027
8.2.10.5.2. Europe
8.2.10.5.2.1. Market
Estimation, 2015 – 2018
8.2.10.5.2.2. Market
Forecast, 2019 – 2027
8.2.10.5.3. Asia
Pacific
8.2.10.5.3.1. Market
Estimation, 2015 – 2018
8.2.10.5.3.2. Market
Forecast, 2019 – 2027
8.2.10.5.4. Middle
East and Africa
8.2.10.5.4.1. Market
Estimation, 2015 – 2018
8.2.10.5.4.2. Market
Forecast, 2019 – 2027
8.2.10.5.5. Latin
America
8.2.10.5.5.1. Market
Estimation, 2015 – 2018
8.2.10.5.5.2. Market
Forecast, 2019 – 2027
8.2.11. Fecal
Occult Testing Products
8.2.11.1. Definition
8.2.11.2. Market
Estimation and Penetration, 2015 – 2018
8.2.11.3. Market
Forecast, 2019 – 2027
8.2.11.4. Compound
Annual Growth Rate (CAGR)
8.2.11.5. Regional
Bifurcation
8.2.11.5.1. North
America
8.2.11.5.1.1. Market
Estimation, 2015 – 2018
8.2.11.5.1.2. Market
Forecast, 2019 – 2027
8.2.11.5.2. Europe
8.2.11.5.2.1. Market
Estimation, 2015 – 2018
8.2.11.5.2.2. Market
Forecast, 2019 – 2027
8.2.11.5.3. Asia
Pacific
8.2.11.5.3.1. Market
Estimation, 2015 – 2018
8.2.11.5.3.2. Market
Forecast, 2019 – 2027
8.2.11.5.4. Middle
East and Africa
8.2.11.5.4.1. Market
Estimation, 2015 – 2018
8.2.11.5.4.2. Market
Forecast, 2019 – 2027
8.2.11.5.5. Latin
America
8.2.11.5.5.1. Market
Estimation, 2015 – 2018
8.2.11.5.5.2. Market
Forecast, 2019 – 2027
8.2.12. Hematology
Testing Products
8.2.12.1. Definition
8.2.12.2. Market
Estimation and Penetration, 2015 – 2018
8.2.12.3. Market
Forecast, 2019 – 2027
8.2.12.4. Compound
Annual Growth Rate (CAGR)
8.2.12.5. Regional
Bifurcation
8.2.12.5.1. North
America
8.2.12.5.1.1. Market
Estimation, 2015 – 2018
8.2.12.5.1.2. Market
Forecast, 2019 – 2027
8.2.12.5.2. Europe
8.2.12.5.2.1. Market
Estimation, 2015 – 2018
8.2.12.5.2.2. Market
Forecast, 2019 – 2027
8.2.12.5.3. Asia
Pacific
8.2.12.5.3.1. Market
Estimation, 2015 – 2018
8.2.12.5.3.2. Market
Forecast, 2019 – 2027
8.2.12.5.4. Middle
East and Africa
8.2.12.5.4.1. Market
Estimation, 2015 – 2018
8.2.12.5.4.2. Market
Forecast, 2019 – 2027
8.2.12.5.5. Latin
America
8.2.12.5.5.1. Market
Estimation, 2015 – 2018
8.2.12.5.5.2. Market
Forecast, 2019 – 2027
8.2.13. HbA1c
and Diabetes Products
8.2.13.1. Definition
8.2.13.2. Market
Estimation and Penetration, 2015 – 2018
8.2.13.3. Market
Forecast, 2019 – 2027
8.2.13.4. Compound
Annual Growth Rate (CAGR)
8.2.13.5. Regional
Bifurcation
8.2.13.5.1. North
America
8.2.13.5.1.1. Market
Estimation, 2015 – 2018
8.2.13.5.1.2. Market
Forecast, 2019 – 2027
8.2.13.5.2. Europe
8.2.13.5.2.1. Market
Estimation, 2015 – 2018
8.2.13.5.2.2. Market
Forecast, 2019 – 2027
8.2.13.5.3. Asia
Pacific
8.2.13.5.3.1. Market
Estimation, 2015 – 2018
8.2.13.5.3.2. Market
Forecast, 2019 – 2027
8.2.13.5.4. Middle
East and Africa
8.2.13.5.4.1. Market
Estimation, 2015 – 2018
8.2.13.5.4.2. Market
Forecast, 2019 – 2027
8.2.13.5.5. Latin
America
8.2.13.5.5.1. Market
Estimation, 2015 – 2018
8.2.13.5.5.2. Market
Forecast, 2019 – 2027
8.2.14. Infectious
Disease Testing Products (Definition, Market Estimation and Penetration, 2015 –
2018, Market Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound
Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia
Pacific, Middle East and Africa, Latin America) and Information on HIV
Infections, Malaria, Syphilis, E.Coli, Influenza, Others)
8.2.14.1. HIV
Infections
8.2.14.2. Malaria
8.2.14.3. Syphilis
8.2.14.4. E.Coli
8.2.14.5. Influenza
8.2.14.6. Others
8.2.15. Others
(CO-Oximeter, etc.)
8.2.15.1. Definition
8.2.15.2. Market
Estimation and Penetration, 2015 – 2018
8.2.15.3. Market
Forecast, 2019 – 2027
8.2.15.4. Compound
Annual Growth Rate (CAGR)
8.2.15.5. Regional
Bifurcation
8.2.15.5.1. North
America
8.2.15.5.1.1. Market
Estimation, 2015 – 2018
8.2.15.5.1.2. Market
Forecast, 2019 – 2027
8.2.15.5.2. Europe
8.2.15.5.2.1. Market
Estimation, 2015 – 2018
8.2.15.5.2.2. Market
Forecast, 2019 – 2027
8.2.15.5.3. Asia
Pacific
8.2.15.5.3.1. Market
Estimation, 2015 – 2018
8.2.15.5.3.2. Market
Forecast, 2019 – 2027
8.2.15.5.4. Middle
East and Africa
8.2.15.5.4.1. Market
Estimation, 2015 – 2018
8.2.15.5.4.2. Market
Forecast, 2019 – 2027
8.2.15.5.5. Latin
America
8.2.15.5.5.1. Market
Estimation, 2015 – 2018
8.2.15.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product Type
9. Global Point of Care (POC) Diagnostic Devices Market Analysis
and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
9.2.1. Dipstick
and Lateral Flow Configurations
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Microfluidics
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.2.3. Magnetic
immunoassay
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 – 2018
9.2.3.3. Market
Forecast, 2019 – 2027
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 – 2018
9.2.3.5.1.2. Market
Forecast, 2019 – 2027
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2018
9.2.3.5.2.2. Market
Forecast, 2019 – 2027
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2018
9.2.3.5.3.2. Market
Forecast, 2019 – 2027
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2018
9.2.3.5.4.2. Market
Forecast, 2019 – 2027
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 – 2018
9.2.3.5.5.2. Market
Forecast, 2019 – 2027
9.2.4. Molecular
Diagnostics
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 – 2018
9.2.4.3. Market
Forecast, 2019 – 2027
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 – 2018
9.2.4.5.1.2. Market
Forecast, 2019 – 2027
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2018
9.2.4.5.2.2. Market
Forecast, 2019 – 2027
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2018
9.2.4.5.3.2. Market
Forecast, 2019 – 2027
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2018
9.2.4.5.4.2. Market
Forecast, 2019 – 2027
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 – 2018
9.2.4.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Formats
10. Global Point of Care (POC) Diagnostic Devices Market Analysis
and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
10.2.1. Handheld
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2018
10.2.1.3. Market
Forecast, 2019 – 2027
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2018
10.2.1.5.1.2. Market
Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2018
10.2.1.5.2.2. Market
Forecast, 2019 – 2027
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2018
10.2.1.5.3.2. Market
Forecast, 2019 – 2027
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2018
10.2.1.5.4.2. Market
Forecast, 2019 – 2027
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2018
10.2.1.5.5.2. Market
Forecast, 2019 – 2027
10.2.2. Benchtop
Models
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2018
10.2.2.3. Market
Forecast, 2019 – 2027
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2018
10.2.2.5.1.2. Market
Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2018
10.2.2.5.2.2. Market
Forecast, 2019 – 2027
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2018
10.2.2.5.3.2. Market
Forecast, 2019 – 2027
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2018
10.2.2.5.4.2. Market
Forecast, 2019 – 2027
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2018
10.2.2.5.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By
Device Type
11. Global Point of Care (POC) Diagnostic Devices Market Analysis
and Forecasts, 2019 – 2027
11.1. Overview
11.2. Global
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
11.2.1. Prescription
Based
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2018
11.2.1.3. Market
Forecast, 2019 – 2027
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2018
11.2.1.5.1.2. Market
Forecast, 2019 – 2027
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2018
11.2.1.5.2.2. Market
Forecast, 2019 – 2027
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2018
11.2.1.5.3.2. Market
Forecast, 2019 – 2027
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2018
11.2.1.5.4.2. Market
Forecast, 2019 – 2027
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2018
11.2.1.5.5.2. Market
Forecast, 2019 – 2027
11.2.2. Over
The Counter (OTC)
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2018
11.2.2.3. Market
Forecast, 2019 – 2027
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2018
11.2.2.5.1.2. Market
Forecast, 2019 – 2027
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2018
11.2.2.5.2.2. Market
Forecast, 2019 – 2027
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2018
11.2.2.5.3.2. Market
Forecast, 2019 – 2027
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2018
11.2.2.5.4.2. Market
Forecast, 2019 – 2027
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2018
11.2.2.5.5.2. Market
Forecast, 2019 – 2027
11.3. Key
Segment for Channeling Investments
11.3.1. By Type
12. Global Point of Care (POC) Diagnostic Devices Market Analysis
and Forecasts, 2019 – 2027
12.1. Overview
12.2. Global
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
12.2.1. Hospitals
(Definition, Market Estimation and Penetration, 2015 – 2018, Market Estimation
(2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Critical Care Units, Neonatal
Intensive Care Unit (NICU), Others)
12.2.1.1. Critical
Care Units
12.2.1.2. Neonatal
Intensive Care Unit (NICU)
12.2.1.3. Others
12.2.2. Private
Clinics
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 – 2018
12.2.2.3. Market
Forecast, 2019 – 2027
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 – 2018
12.2.2.5.1.2. Market
Forecast, 2019 – 2027
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 – 2018
12.2.2.5.2.2. Market
Forecast, 2019 – 2027
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 – 2018
12.2.2.5.3.2. Market
Forecast, 2019 – 2027
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 – 2018
12.2.2.5.4.2. Market
Forecast, 2019 – 2027
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 – 2018
12.2.2.5.5.2. Market
Forecast, 2019 – 2027
12.2.3. Diagnostic
Centres
12.2.3.1. Definition
12.2.3.2. Market
Estimation and Penetration, 2015 – 2018
12.2.3.3. Market
Forecast, 2019 – 2027
12.2.3.4. Compound
Annual Growth Rate (CAGR)
12.2.3.5. Regional
Bifurcation
12.2.3.5.1. North
America
12.2.3.5.1.1. Market
Estimation, 2015 – 2018
12.2.3.5.1.2. Market
Forecast, 2019 – 2027
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 – 2018
12.2.3.5.2.2. Market
Forecast, 2019 – 2027
12.2.3.5.3. Asia
Pacific
12.2.3.5.3.1. Market
Estimation, 2015 – 2018
12.2.3.5.3.2. Market
Forecast, 2019 – 2027
12.2.3.5.4. Middle
East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 – 2018
12.2.3.5.4.2. Market
Forecast, 2019 – 2027
12.2.3.5.5. Latin
America
12.2.3.5.5.1. Market
Estimation, 2015 – 2018
12.2.3.5.5.2. Market
Forecast, 2019 – 2027
12.2.4. Home
Care Settings
12.2.4.1. Definition
12.2.4.2. Market
Estimation and Penetration, 2015 – 2018
12.2.4.3. Market
Forecast, 2019 – 2027
12.2.4.4. Compound
Annual Growth Rate (CAGR)
12.2.4.5. Regional
Bifurcation
12.2.4.5.1. North
America
12.2.4.5.1.1. Market
Estimation, 2015 – 2018
12.2.4.5.1.2. Market
Forecast, 2019 – 2027
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation, 2015 – 2018
12.2.4.5.2.2. Market
Forecast, 2019 – 2027
12.2.4.5.3. Asia
Pacific
12.2.4.5.3.1. Market
Estimation, 2015 – 2018
12.2.4.5.3.2. Market
Forecast, 2019 – 2027
12.2.4.5.4. Middle
East and Africa
12.2.4.5.4.1. Market
Estimation, 2015 – 2018
12.2.4.5.4.2. Market
Forecast, 2019 – 2027
12.2.4.5.5. Latin
America
12.2.4.5.5.1. Market
Estimation, 2015 – 2018
12.2.4.5.5.2. Market
Forecast, 2019 – 2027
12.2.5. Doctor’s
Offices
12.2.5.1. Definition
12.2.5.2. Market
Estimation and Penetration, 2015 – 2018
12.2.5.3. Market
Forecast, 2019 – 2027
12.2.5.4. Compound
Annual Growth Rate (CAGR)
12.2.5.5. Regional
Bifurcation
12.2.5.5.1. North
America
12.2.5.5.1.1. Market
Estimation, 2015 – 2018
12.2.5.5.1.2. Market
Forecast, 2019 – 2027
12.2.5.5.2. Europe
12.2.5.5.2.1. Market
Estimation, 2015 – 2018
12.2.5.5.2.2. Market
Forecast, 2019 – 2027
12.2.5.5.3. Asia
Pacific
12.2.5.5.3.1. Market
Estimation, 2015 – 2018
12.2.5.5.3.2. Market
Forecast, 2019 – 2027
12.2.5.5.4. Middle
East and Africa
12.2.5.5.4.1. Market
Estimation, 2015 – 2018
12.2.5.5.4.2. Market
Forecast, 2019 – 2027
12.2.5.5.5. Latin
America
12.2.5.5.5.1. Market
Estimation, 2015 – 2018
12.2.5.5.5.2. Market
Forecast, 2019 – 2027
12.2.6. Ambulatory
Care Centers
12.2.6.1. Definition
12.2.6.2. Market
Estimation and Penetration, 2015 – 2018
12.2.6.3. Market
Forecast, 2019 – 2027
12.2.6.4. Compound
Annual Growth Rate (CAGR)
12.2.6.5. Regional
Bifurcation
12.2.6.5.1. North
America
12.2.6.5.1.1. Market
Estimation, 2015 – 2018
12.2.6.5.1.2. Market
Forecast, 2019 – 2027
12.2.6.5.2. Europe
12.2.6.5.2.1. Market
Estimation, 2015 – 2018
12.2.6.5.2.2. Market
Forecast, 2019 – 2027
12.2.6.5.3. Asia
Pacific
12.2.6.5.3.1. Market
Estimation, 2015 – 2018
12.2.6.5.3.2. Market
Forecast, 2019 – 2027
12.2.6.5.4. Middle
East and Africa
12.2.6.5.4.1. Market
Estimation, 2015 – 2018
12.2.6.5.4.2. Market
Forecast, 2019 – 2027
12.2.6.5.5. Latin
America
12.2.6.5.5.1. Market
Estimation, 2015 – 2018
12.2.6.5.5.2. Market
Forecast, 2019 – 2027
12.2.7. Emergency
Departments
12.2.7.1. Definition
12.2.7.2. Market
Estimation and Penetration, 2015 – 2018
12.2.7.3. Market
Forecast, 2019 – 2027
12.2.7.4. Compound
Annual Growth Rate (CAGR)
12.2.7.5. Regional
Bifurcation
12.2.7.5.1. North
America
12.2.7.5.1.1. Market
Estimation, 2015 – 2018
12.2.7.5.1.2. Market
Forecast, 2019 – 2027
12.2.7.5.2. Europe
12.2.7.5.2.1. Market
Estimation, 2015 – 2018
12.2.7.5.2.2. Market
Forecast, 2019 – 2027
12.2.7.5.3. Asia
Pacific
12.2.7.5.3.1. Market
Estimation, 2015 – 2018
12.2.7.5.3.2. Market
Forecast, 2019 – 2027
12.2.7.5.4. Middle
East and Africa
12.2.7.5.4.1. Market
Estimation, 2015 – 2018
12.2.7.5.4.2. Market
Forecast, 2019 – 2027
12.2.7.5.5. Latin
America
12.2.7.5.5.1. Market
Estimation, 2015 – 2018
12.2.7.5.5.2. Market
Forecast, 2019 – 2027
12.2.8. Laboratories
12.2.8.1. Definition
12.2.8.2. Market
Estimation and Penetration, 2015 – 2018
12.2.8.3. Market
Forecast, 2019 – 2027
12.2.8.4. Compound
Annual Growth Rate (CAGR)
12.2.8.5. Regional
Bifurcation
12.2.8.5.1. North
America
12.2.8.5.1.1. Market
Estimation, 2015 – 2018
12.2.8.5.1.2. Market
Forecast, 2019 – 2027
12.2.8.5.2. Europe
12.2.8.5.2.1. Market
Estimation, 2015 – 2018
12.2.8.5.2.2. Market
Forecast, 2019 – 2027
12.2.8.5.3. Asia
Pacific
12.2.8.5.3.1. Market
Estimation, 2015 – 2018
12.2.8.5.3.2. Market
Forecast, 2019 – 2027
12.2.8.5.4. Middle
East and Africa
12.2.8.5.4.1. Market
Estimation, 2015 – 2018
12.2.8.5.4.2. Market
Forecast, 2019 – 2027
12.2.8.5.5. Latin
America
12.2.8.5.5.1. Market
Estimation, 2015 – 2018
12.2.8.5.5.2. Market
Forecast, 2019 – 2027
12.2.9. Others
12.2.9.1. Definition
12.2.9.2. Market
Estimation and Penetration, 2015 – 2018
12.2.9.3. Market
Forecast, 2019 – 2027
12.2.9.4. Compound
Annual Growth Rate (CAGR)
12.2.9.5. Regional
Bifurcation
12.2.9.5.1. North
America
12.2.9.5.1.1. Market
Estimation, 2015 – 2018
12.2.9.5.1.2. Market
Forecast, 2019 – 2027
12.2.9.5.2. Europe
12.2.9.5.2.1. Market
Estimation, 2015 – 2018
12.2.9.5.2.2. Market
Forecast, 2019 – 2027
12.2.9.5.3. Asia
Pacific
12.2.9.5.3.1. Market
Estimation, 2015 – 2018
12.2.9.5.3.2. Market
Forecast, 2019 – 2027
12.2.9.5.4. Middle
East and Africa
12.2.9.5.4.1. Market
Estimation, 2015 – 2018
12.2.9.5.4.2. Market
Forecast, 2019 – 2027
12.2.9.5.5. Latin
America
12.2.9.5.5.1. Market
Estimation, 2015 – 2018
12.2.9.5.5.2. Market
Forecast, 2019 – 2027
12.3. Key
Segment for Channeling Investments
12.3.1. By End
Users
13. North America Point of Care (POC) Diagnostic Devices Market
Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. North
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
13.2. North
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.2.1. Albumin
Analyzers (Albumin Testing)
13.2.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
13.2.3. Cardiac
Marker Analyzers
13.2.4. Clinical
Chemistry Analyzers
13.2.5. Coagulation
Analyzer / Microcoagulation System
13.2.6. Creatinine
Analyzer
13.2.7. CRP
Analyzer (C-Reactive Protein Analyzers)
13.2.8. Laboratory
Blood Glucose Analyzers
13.2.9. Urinalysis
Products
13.2.9.1. Analyzers
13.2.9.2. Strips
13.2.9.3. Controls
13.2.9.4. Supplies
13.2.10. Drugs-of-abuse
Testing Products
13.2.11. Fecal
Occult Testing Products
13.2.12. Hematology
Testing Products
13.2.13. HbA1c
and Diabetes Products
13.2.14. Infectious
Disease Testing Products
13.2.14.1. HIV
Infections
13.2.14.2. Malaria
13.2.14.3. Syphilis
13.2.14.4. E.Coli
13.2.14.5. Influenza
13.2.14.6. Others
13.2.15. Others
(CO-Oximeter, etc.)
13.3. North
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
13.3.1. Dipstick
and Lateral Flow Configurations
13.3.2. Microfluidics
13.3.3. Magnetic
immunoassay
13.3.4. Molecular
Diagnostics
13.4. North
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
13.4.1. Handheld
13.4.2. Benchtop
Models
13.5. North
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
13.5.1. Prescription
Based
13.5.2. Over
The Counter (OTC)
13.6. North
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.1. Hospitals
13.6.1.1. Critical
Care Units
13.6.1.2. Neonatal
Intensive Care Unit (NICU)
13.6.1.3. Others
13.6.2. Private
Clinics
13.6.3. Diagnostic
Centres
13.6.4. Home
Care Settings
13.6.5. Doctor’s
Offices
13.6.6. Ambulatory
Care Centers
13.6.7. Emergency
Departments
13.6.8. Laboratories
13.6.9. Others
13.7. North
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
13.7.1.1.1. Albumin
Analyzers (Albumin Testing)
13.7.1.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
13.7.1.1.3. Cardiac
Marker Analyzers
13.7.1.1.4. Clinical
Chemistry Analyzers
13.7.1.1.5. Coagulation
Analyzer / Microcoagulation System
13.7.1.1.6. Creatinine
Analyzer
13.7.1.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
13.7.1.1.8. Laboratory
Blood Glucose Analyzers
13.7.1.1.9. Urinalysis
Products
13.7.1.1.9.1. Analyzers
13.7.1.1.9.2. Strips
13.7.1.1.9.3. Controls
13.7.1.1.9.4. Supplies
13.7.1.1.10. Drugs-of-abuse
Testing Products
13.7.1.1.11. Fecal
Occult Testing Products
13.7.1.1.12. Hematology
Testing Products
13.7.1.1.13. HbA1c
and Diabetes Products
13.7.1.1.14. Infectious
Disease Testing Products
13.7.1.1.14.1. HIV
Infections
13.7.1.1.14.2. Malaria
13.7.1.1.14.3. Syphilis
13.7.1.1.14.4. E.Coli
13.7.1.1.14.5. Influenza
13.7.1.1.14.6. Others
13.7.1.1.15. Others
(CO-Oximeter, etc.)
13.7.1.2. U.S
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
13.7.1.2.1. Dipstick
and Lateral Flow Configurations
13.7.1.2.2. Microfluidics
13.7.1.2.3. Magnetic
immunoassay
13.7.1.2.4. Molecular
Diagnostics
13.7.1.3. U.S
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
13.7.1.3.1. Handheld
13.7.1.3.2. Benchtop
Models
13.7.1.4. U.S
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
13.7.1.4.1. Prescription
Based
13.7.1.4.2. Over
The Counter (OTC)
13.7.1.5. U.S
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
13.7.1.5.1. Hospitals
13.7.1.5.1.1. Critical
Care Units
13.7.1.5.1.2. Neonatal
Intensive Care Unit (NICU)
13.7.1.5.1.3. Others
13.7.1.5.2. Private
Clinics
13.7.1.5.3. Diagnostic
Centres
13.7.1.5.4. Home
Care Settings
13.7.1.5.5. Doctor’s
Offices
13.7.1.5.6. Ambulatory
Care Centers
13.7.1.5.7. Emergency
Departments
13.7.1.5.8. Laboratories
13.7.1.5.9. Others
13.7.2. Canada
13.7.2.1. Canada
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
13.7.2.1.1. Albumin
Analyzers (Albumin Testing)
13.7.2.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
13.7.2.1.3. Cardiac
Marker Analyzers
13.7.2.1.4. Clinical
Chemistry Analyzers
13.7.2.1.5. Coagulation
Analyzer / Microcoagulation System
13.7.2.1.6. Creatinine
Analyzer
13.7.2.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
13.7.2.1.8. Laboratory
Blood Glucose Analyzers
13.7.2.1.9. Urinalysis
Products
13.7.2.1.9.1. Analyzers
13.7.2.1.9.2. Strips
13.7.2.1.9.3. Controls
13.7.2.1.9.4. Supplies
13.7.2.1.10. Drugs-of-abuse
Testing Products
13.7.2.1.11. Fecal
Occult Testing Products
13.7.2.1.12. Hematology
Testing Products
13.7.2.1.13. HbA1c
and Diabetes Products
13.7.2.1.14. Infectious
Disease Testing Products
13.7.2.1.14.1. HIV
Infections
13.7.2.1.14.2. Malaria
13.7.2.1.14.3. Syphilis
13.7.2.1.14.4. E.Coli
13.7.2.1.14.5. Influenza
13.7.2.1.14.6. Others
13.7.2.1.15. Others
(CO-Oximeter, etc.)
13.7.2.2. Canada
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
13.7.2.2.1. Dipstick
and Lateral Flow Configurations
13.7.2.2.2. Microfluidics
13.7.2.2.3. Magnetic
immunoassay
13.7.2.2.4. Molecular
Diagnostics
13.7.2.3. Canada
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
13.7.2.3.1. Handheld
13.7.2.3.2. Benchtop
Models
13.7.2.4. Canada
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
13.7.2.4.1. Prescription
Based
13.7.2.4.2. Over
The Counter (OTC)
13.7.2.5. Canada
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
13.7.2.5.1. Hospitals
13.7.2.5.1.1. Critical
Care Units
13.7.2.5.1.2. Neonatal
Intensive Care Unit (NICU)
13.7.2.5.1.3. Others
13.7.2.5.2. Private
Clinics
13.7.2.5.3. Diagnostic
Centres
13.7.2.5.4. Home
Care Settings
13.7.2.5.5. Doctor’s
Offices
13.7.2.5.6. Ambulatory
Care Centers
13.7.2.5.7. Emergency
Departments
13.7.2.5.8. Laboratories
13.7.2.5.9. Others
13.7.3. Mexico
13.7.3.1. Mexico
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
13.7.3.1.1. Albumin
Analyzers (Albumin Testing)
13.7.3.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
13.7.3.1.3. Cardiac
Marker Analyzers
13.7.3.1.4. Clinical
Chemistry Analyzers
13.7.3.1.5. Coagulation
Analyzer / Microcoagulation System
13.7.3.1.6. Creatinine
Analyzer
13.7.3.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
13.7.3.1.8. Laboratory
Blood Glucose Analyzers
13.7.3.1.9. Urinalysis
Products
13.7.3.1.9.1. Analyzers
13.7.3.1.9.2. Strips
13.7.3.1.9.3. Controls
13.7.3.1.9.4. Supplies
13.7.3.1.10. Drugs-of-abuse
Testing Products
13.7.3.1.11. Fecal
Occult Testing Products
13.7.3.1.12. Hematology
Testing Products
13.7.3.1.13. HbA1c
and Diabetes Products
13.7.3.1.14. Infectious
Disease Testing Products
13.7.3.1.14.1. HIV
Infections
13.7.3.1.14.2. Malaria
13.7.3.1.14.3. Syphilis
13.7.3.1.14.4. E.Coli
13.7.3.1.14.5. Influenza
13.7.3.1.14.6. Others
13.7.3.1.15. Others
(CO-Oximeter, etc.)
13.7.3.2. Mexico
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
13.7.3.2.1. Dipstick
and Lateral Flow Configurations
13.7.3.2.2. Microfluidics
13.7.3.2.3. Magnetic
immunoassay
13.7.3.2.4. Molecular
Diagnostics
13.7.3.3. Mexico
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
13.7.3.3.1. Handheld
13.7.3.3.2. Benchtop
Models
13.7.3.4. Mexico
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
13.7.3.4.1. Prescription
Based
13.7.3.4.2. Over
The Counter (OTC)
13.7.3.5. Mexico
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
13.7.3.5.1. Hospitals
13.7.3.5.1.1. Critical
Care Units
13.7.3.5.1.2. Neonatal
Intensive Care Unit (NICU)
13.7.3.5.1.3. Others
13.7.3.5.2. Private
Clinics
13.7.3.5.3. Diagnostic
Centres
13.7.3.5.4. Home
Care Settings
13.7.3.5.5. Doctor’s
Offices
13.7.3.5.6. Ambulatory
Care Centers
13.7.3.5.7. Emergency
Departments
13.7.3.5.8. Laboratories
13.7.3.5.9. Others
13.7.4. Rest of
North America
13.7.4.1. Rest
of North America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Product Type
13.7.4.1.1. Albumin
Analyzers (Albumin Testing)
13.7.4.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
13.7.4.1.3. Cardiac
Marker Analyzers
13.7.4.1.4. Clinical
Chemistry Analyzers
13.7.4.1.5. Coagulation
Analyzer / Microcoagulation System
13.7.4.1.6. Creatinine
Analyzer
13.7.4.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
13.7.4.1.8. Laboratory
Blood Glucose Analyzers
13.7.4.1.9. Urinalysis
Products
13.7.4.1.9.1. Analyzers
13.7.4.1.9.2. Strips
13.7.4.1.9.3. Controls
13.7.4.1.9.4. Supplies
13.7.4.1.10. Drugs-of-abuse
Testing Products
13.7.4.1.11. Fecal
Occult Testing Products
13.7.4.1.12. Hematology
Testing Products
13.7.4.1.13. HbA1c
and Diabetes Products
13.7.4.1.14. Infectious
Disease Testing Products
13.7.4.1.14.1. HIV
Infections
13.7.4.1.14.2. Malaria
13.7.4.1.14.3. Syphilis
13.7.4.1.14.4. E.Coli
13.7.4.1.14.5. Influenza
13.7.4.1.14.6. Others
13.7.4.1.15. Others
(CO-Oximeter, etc.)
13.7.4.2. Rest
of North America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Formats
13.7.4.2.1. Dipstick
and Lateral Flow Configurations
13.7.4.2.2. Microfluidics
13.7.4.2.3. Magnetic
immunoassay
13.7.4.2.4. Molecular
Diagnostics
13.7.4.3. Rest
of North America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Device Type
13.7.4.3.1. Handheld
13.7.4.3.2. Benchtop
Models
13.7.4.4. Rest
of North America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Type
13.7.4.4.1. Prescription
Based
13.7.4.4.2. Over
The Counter (OTC)
13.7.4.5. Rest
of North America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By End Users
13.7.4.5.1. Hospitals
13.7.4.5.1.1. Critical
Care Units
13.7.4.5.1.2. Neonatal
Intensive Care Unit (NICU)
13.7.4.5.1.3. Others
13.7.4.5.2. Private
Clinics
13.7.4.5.3. Diagnostic
Centres
13.7.4.5.4. Home
Care Settings
13.7.4.5.5. Doctor’s
Offices
13.7.4.5.6. Ambulatory
Care Centers
13.7.4.5.7. Emergency
Departments
13.7.4.5.8. Laboratories
13.7.4.5.9. Others
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Product Type
13.8.3. By Formats
13.8.4. By
Device Type
13.8.5. By Type
13.8.6. By End
Users
14. Europe Point of Care (POC) Diagnostic Devices Market Analysis
and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Europe
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
14.2. Europe
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
14.2.1. Albumin
Analyzers (Albumin Testing)
14.2.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.2.3. Cardiac
Marker Analyzers
14.2.4. Clinical
Chemistry Analyzers
14.2.5. Coagulation
Analyzer / Microcoagulation System
14.2.6. Creatinine
Analyzer
14.2.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.2.8. Laboratory
Blood Glucose Analyzers
14.2.9. Urinalysis
Products
14.2.9.1. Analyzers
14.2.9.2. Strips
14.2.9.3. Controls
14.2.9.4. Supplies
14.2.10. Drugs-of-abuse
Testing Products
14.2.11. Fecal
Occult Testing Products
14.2.12. Hematology
Testing Products
14.2.13. HbA1c
and Diabetes Products
14.2.14. Infectious
Disease Testing Products
14.2.14.1. HIV
Infections
14.2.14.2. Malaria
14.2.14.3. Syphilis
14.2.14.4. E.Coli
14.2.14.5. Influenza
14.2.14.6. Others
14.2.15. Others
(CO-Oximeter, etc.)
14.3. Europe
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
14.3.1. Dipstick
and Lateral Flow Configurations
14.3.2. Microfluidics
14.3.3. Magnetic
immunoassay
14.3.4. Molecular
Diagnostics
14.4. Europe
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
14.4.1. Handheld
14.4.2. Benchtop
Models
14.5. Europe
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
14.5.1. Prescription
Based
14.5.2. Over
The Counter (OTC)
14.6. Europe
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.1. Hospitals
14.6.1.1. Critical
Care Units
14.6.1.2. Neonatal
Intensive Care Unit (NICU)
14.6.1.3. Others
14.6.2. Private
Clinics
14.6.3. Diagnostic
Centres
14.6.4. Home
Care Settings
14.6.5. Doctor’s
Offices
14.6.6. Ambulatory
Care Centers
14.6.7. Emergency
Departments
14.6.8. Laboratories
14.6.9. Others
14.7. Europe
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Country
14.7.1. France
14.7.1.1. France
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
14.7.1.1.1. Albumin
Analyzers (Albumin Testing)
14.7.1.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.1.1.3. Cardiac
Marker Analyzers
14.7.1.1.4. Clinical
Chemistry Analyzers
14.7.1.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.1.1.6. Creatinine
Analyzer
14.7.1.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.1.1.8. Laboratory
Blood Glucose Analyzers
14.7.1.1.9. Urinalysis
Products
14.7.1.1.9.1. Analyzers
14.7.1.1.9.2. Strips
14.7.1.1.9.3. Controls
14.7.1.1.9.4. Supplies
14.7.1.1.10. Drugs-of-abuse
Testing Products
14.7.1.1.11. Fecal
Occult Testing Products
14.7.1.1.12. Hematology
Testing Products
14.7.1.1.13. HbA1c
and Diabetes Products
14.7.1.1.14. Infectious
Disease Testing Products
14.7.1.1.14.1. HIV
Infections
14.7.1.1.14.2. Malaria
14.7.1.1.14.3. Syphilis
14.7.1.1.14.4. E.Coli
14.7.1.1.14.5. Influenza
14.7.1.1.14.6. Others
14.7.1.1.15. Others
(CO-Oximeter, etc.)
14.7.1.2. France
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
14.7.1.2.1. Dipstick
and Lateral Flow Configurations
14.7.1.2.2. Microfluidics
14.7.1.2.3. Magnetic
immunoassay
14.7.1.2.4. Molecular
Diagnostics
14.7.1.3. France
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
14.7.1.3.1. Handheld
14.7.1.3.2. Benchtop
Models
14.7.1.4. France
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
14.7.1.4.1. Prescription
Based
14.7.1.4.2. Over
The Counter (OTC)
14.7.1.5. France
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.1.5.1. Hospitals
14.7.1.5.1.1. Critical
Care Units
14.7.1.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.1.5.1.3. Others
14.7.1.5.2. Private
Clinics
14.7.1.5.3. Diagnostic
Centres
14.7.1.5.4. Home
Care Settings
14.7.1.5.5. Doctor’s
Offices
14.7.1.5.6. Ambulatory
Care Centers
14.7.1.5.7. Emergency
Departments
14.7.1.5.8. Laboratories
14.7.1.5.9. Others
14.7.2. The UK
14.7.2.1. The
UK Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.7.2.1.1. Albumin
Analyzers (Albumin Testing)
14.7.2.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.2.1.3. Cardiac
Marker Analyzers
14.7.2.1.4. Clinical
Chemistry Analyzers
14.7.2.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.2.1.6. Creatinine
Analyzer
14.7.2.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.2.1.8. Laboratory
Blood Glucose Analyzers
14.7.2.1.9. Urinalysis
Products
14.7.2.1.9.1. Analyzers
14.7.2.1.9.2. Strips
14.7.2.1.9.3. Controls
14.7.2.1.9.4. Supplies
14.7.2.1.10. Drugs-of-abuse
Testing Products
14.7.2.1.11. Fecal
Occult Testing Products
14.7.2.1.12. Hematology
Testing Products
14.7.2.1.13. HbA1c
and Diabetes Products
14.7.2.1.14. Infectious
Disease Testing Products
14.7.2.1.14.1. HIV
Infections
14.7.2.1.14.2. Malaria
14.7.2.1.14.3. Syphilis
14.7.2.1.14.4. E.Coli
14.7.2.1.14.5. Influenza
14.7.2.1.14.6. Others
14.7.2.1.15. Others
(CO-Oximeter, etc.)
14.7.2.2. The
UK Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
14.7.2.2.1. Dipstick
and Lateral Flow Configurations
14.7.2.2.2. Microfluidics
14.7.2.2.3. Magnetic
immunoassay
14.7.2.2.4. Molecular
Diagnostics
14.7.2.3. The
UK Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
14.7.2.3.1. Handheld
14.7.2.3.2. Benchtop
Models
14.7.2.4. The
UK Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
14.7.2.4.1. Prescription
Based
14.7.2.4.2. Over
The Counter (OTC)
14.7.2.5. The
UK Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.2.5.1. Hospitals
14.7.2.5.1.1. Critical
Care Units
14.7.2.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.2.5.1.3. Others
14.7.2.5.2. Private
Clinics
14.7.2.5.3. Diagnostic
Centres
14.7.2.5.4. Home
Care Settings
14.7.2.5.5. Doctor’s
Offices
14.7.2.5.6. Ambulatory
Care Centers
14.7.2.5.7. Emergency
Departments
14.7.2.5.8. Laboratories
14.7.2.5.9. Others
14.7.3. Spain
14.7.3.1. Spain
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
14.7.3.1.1. Albumin
Analyzers (Albumin Testing)
14.7.3.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.3.1.3. Cardiac
Marker Analyzers
14.7.3.1.4. Clinical
Chemistry Analyzers
14.7.3.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.3.1.6. Creatinine
Analyzer
14.7.3.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.3.1.8. Laboratory
Blood Glucose Analyzers
14.7.3.1.9. Urinalysis
Products
14.7.3.1.9.1. Analyzers
14.7.3.1.9.2. Strips
14.7.3.1.9.3. Controls
14.7.3.1.9.4. Supplies
14.7.3.1.10. Drugs-of-abuse
Testing Products
14.7.3.1.11. Fecal
Occult Testing Products
14.7.3.1.12. Hematology
Testing Products
14.7.3.1.13. HbA1c
and Diabetes Products
14.7.3.1.14. Infectious
Disease Testing Products
14.7.3.1.14.1. HIV
Infections
14.7.3.1.14.2. Malaria
14.7.3.1.14.3. Syphilis
14.7.3.1.14.4. E.Coli
14.7.3.1.14.5. Influenza
14.7.3.1.14.6. Others
14.7.3.1.15. Others
(CO-Oximeter, etc.)
14.7.3.2. Spain
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
14.7.3.2.1. Dipstick
and Lateral Flow Configurations
14.7.3.2.2. Microfluidics
14.7.3.2.3. Magnetic
immunoassay
14.7.3.2.4. Molecular
Diagnostics
14.7.3.3. Spain
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
14.7.3.3.1. Handheld
14.7.3.3.2. Benchtop
Models
14.7.3.4. Spain
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
14.7.3.4.1. Prescription
Based
14.7.3.4.2. Over
The Counter (OTC)
14.7.3.5. Spain
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.3.5.1. Hospitals
14.7.3.5.1.1. Critical
Care Units
14.7.3.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.3.5.1.3. Others
14.7.3.5.2. Private
Clinics
14.7.3.5.3. Diagnostic
Centres
14.7.3.5.4. Home
Care Settings
14.7.3.5.5. Doctor’s
Offices
14.7.3.5.6. Ambulatory
Care Centers
14.7.3.5.7. Emergency
Departments
14.7.3.5.8. Laboratories
14.7.3.5.9. Others
14.7.4. Germany
14.7.4.1. Germany
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
14.7.4.1.1. Albumin
Analyzers (Albumin Testing)
14.7.4.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.4.1.3. Cardiac
Marker Analyzers
14.7.4.1.4. Clinical
Chemistry Analyzers
14.7.4.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.4.1.6. Creatinine
Analyzer
14.7.4.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.4.1.8. Laboratory
Blood Glucose Analyzers
14.7.4.1.9. Urinalysis
Products
14.7.4.1.9.1. Analyzers
14.7.4.1.9.2. Strips
14.7.4.1.9.3. Controls
14.7.4.1.9.4. Supplies
14.7.4.1.10. Drugs-of-abuse
Testing Products
14.7.4.1.11. Fecal
Occult Testing Products
14.7.4.1.12. Hematology
Testing Products
14.7.4.1.13. HbA1c
and Diabetes Products
14.7.4.1.14. Infectious
Disease Testing Products
14.7.4.1.14.1. HIV
Infections
14.7.4.1.14.2. Malaria
14.7.4.1.14.3. Syphilis
14.7.4.1.14.4. E.Coli
14.7.4.1.14.5. Influenza
14.7.4.1.14.6. Others
14.7.4.1.15. Others
(CO-Oximeter, etc.)
14.7.4.2. Germany
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
14.7.4.2.1. Dipstick
and Lateral Flow Configurations
14.7.4.2.2. Microfluidics
14.7.4.2.3. Magnetic
immunoassay
14.7.4.2.4. Molecular
Diagnostics
14.7.4.3. Germany
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
14.7.4.3.1. Handheld
14.7.4.3.2. Benchtop
Models
14.7.4.4. Germany
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
14.7.4.4.1. Prescription
Based
14.7.4.4.2. Over
The Counter (OTC)
14.7.4.5. Germany
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.4.5.1. Hospitals
14.7.4.5.1.1. Critical
Care Units
14.7.4.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.4.5.1.3. Others
14.7.4.5.2. Private
Clinics
14.7.4.5.3. Diagnostic
Centres
14.7.4.5.4. Home
Care Settings
14.7.4.5.5. Doctor’s
Offices
14.7.4.5.6. Ambulatory
Care Centers
14.7.4.5.7. Emergency
Departments
14.7.4.5.8. Laboratories
14.7.4.5.9. Others
14.7.5. Italy
14.7.5.1. Italy
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
14.7.5.1.1. Albumin
Analyzers (Albumin Testing)
14.7.5.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.5.1.3. Cardiac
Marker Analyzers
14.7.5.1.4. Clinical
Chemistry Analyzers
14.7.5.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.5.1.6. Creatinine
Analyzer
14.7.5.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.5.1.8. Laboratory
Blood Glucose Analyzers
14.7.5.1.9. Urinalysis
Products
14.7.5.1.9.1. Analyzers
14.7.5.1.9.2. Strips
14.7.5.1.9.3. Controls
14.7.5.1.9.4. Supplies
14.7.5.1.10. Drugs-of-abuse
Testing Products
14.7.5.1.11. Fecal
Occult Testing Products
14.7.5.1.12. Hematology
Testing Products
14.7.5.1.13. HbA1c
and Diabetes Products
14.7.5.1.14. Infectious
Disease Testing Products
14.7.5.1.14.1. HIV
Infections
14.7.5.1.14.2. Malaria
14.7.5.1.14.3. Syphilis
14.7.5.1.14.4. E.Coli
14.7.5.1.14.5. Influenza
14.7.5.1.14.6. Others
14.7.5.1.15. Others
(CO-Oximeter, etc.)
14.7.5.2. Italy
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
14.7.5.2.1. Dipstick
and Lateral Flow Configurations
14.7.5.2.2. Microfluidics
14.7.5.2.3. Magnetic
immunoassay
14.7.5.2.4. Molecular
Diagnostics
14.7.5.3. Italy
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
14.7.5.3.1. Handheld
14.7.5.3.2. Benchtop
Models
14.7.5.4. Italy
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
14.7.5.4.1. Prescription
Based
14.7.5.4.2. Over
The Counter (OTC)
14.7.5.5. Italy
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.5.5.1. Hospitals
14.7.5.5.1.1. Critical
Care Units
14.7.5.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.5.5.1.3. Others
14.7.5.5.2. Private
Clinics
14.7.5.5.3. Diagnostic
Centres
14.7.5.5.4. Home
Care Settings
14.7.5.5.5. Doctor’s
Offices
14.7.5.5.6. Ambulatory
Care Centers
14.7.5.5.7. Emergency
Departments
14.7.5.5.8. Laboratories
14.7.5.5.9. Others
14.7.6. Nordic
Countries
14.7.6.1. Nordic
Countries Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.7.6.1.1. Albumin
Analyzers (Albumin Testing)
14.7.6.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.6.1.3. Cardiac
Marker Analyzers
14.7.6.1.4. Clinical
Chemistry Analyzers
14.7.6.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.6.1.6. Creatinine
Analyzer
14.7.6.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.6.1.8. Laboratory
Blood Glucose Analyzers
14.7.6.1.9. Urinalysis
Products
14.7.6.1.9.1. Analyzers
14.7.6.1.9.2. Strips
14.7.6.1.9.3. Controls
14.7.6.1.9.4. Supplies
14.7.6.1.10. Drugs-of-abuse
Testing Products
14.7.6.1.11. Fecal
Occult Testing Products
14.7.6.1.12. Hematology
Testing Products
14.7.6.1.13. HbA1c
and Diabetes Products
14.7.6.1.14. Infectious
Disease Testing Products
14.7.6.1.14.1. HIV
Infections
14.7.6.1.14.2. Malaria
14.7.6.1.14.3. Syphilis
14.7.6.1.14.4. E.Coli
14.7.6.1.14.5. Influenza
14.7.6.1.14.6. Others
14.7.6.1.15. Others
(CO-Oximeter, etc.)
14.7.6.2. Nordic
Countries Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
14.7.6.2.1. Dipstick
and Lateral Flow Configurations
14.7.6.2.2. Microfluidics
14.7.6.2.3. Magnetic
immunoassay
14.7.6.2.4. Molecular
Diagnostics
14.7.6.3. Nordic
Countries Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
14.7.6.3.1. Handheld
14.7.6.3.2. Benchtop
Models
14.7.6.4. Nordic
Countries Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
14.7.6.4.1. Prescription
Based
14.7.6.4.2. Over
The Counter (OTC)
14.7.6.5. Nordic
Countries Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.6.5.1. Hospitals
14.7.6.5.1.1. Critical
Care Units
14.7.6.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.6.5.1.3. Others
14.7.6.5.2. Private
Clinics
14.7.6.5.3. Diagnostic
Centres
14.7.6.5.4. Home
Care Settings
14.7.6.5.5. Doctor’s
Offices
14.7.6.5.6. Ambulatory
Care Centers
14.7.6.5.7. Emergency
Departments
14.7.6.5.8. Laboratories
14.7.6.5.9. Others
14.7.6.6. Nordic
Countries Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux
Union Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.7.7.1.1. Albumin
Analyzers (Albumin Testing)
14.7.7.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.7.1.3. Cardiac
Marker Analyzers
14.7.7.1.4. Clinical
Chemistry Analyzers
14.7.7.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.7.1.6. Creatinine
Analyzer
14.7.7.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.7.1.8. Laboratory
Blood Glucose Analyzers
14.7.7.1.9. Urinalysis
Products
14.7.7.1.9.1. Analyzers
14.7.7.1.9.2. Strips
14.7.7.1.9.3. Controls
14.7.7.1.9.4. Supplies
14.7.7.1.10. Drugs-of-abuse
Testing Products
14.7.7.1.11. Fecal
Occult Testing Products
14.7.7.1.12. Hematology
Testing Products
14.7.7.1.13. HbA1c
and Diabetes Products
14.7.7.1.14. Infectious
Disease Testing Products
14.7.7.1.14.1. HIV
Infections
14.7.7.1.14.2. Malaria
14.7.7.1.14.3. Syphilis
14.7.7.1.14.4. E.Coli
14.7.7.1.14.5. Influenza
14.7.7.1.14.6. Others
14.7.7.1.15. Others
(CO-Oximeter, etc.)
14.7.7.2. Benelux
Union Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
14.7.7.2.1. Dipstick
and Lateral Flow Configurations
14.7.7.2.2. Microfluidics
14.7.7.2.3. Magnetic
immunoassay
14.7.7.2.4. Molecular
Diagnostics
14.7.7.3. Benelux
Union Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
14.7.7.3.1. Handheld
14.7.7.3.2. Benchtop
Models
14.7.7.4. Benelux
Union Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
14.7.7.4.1. Prescription
Based
14.7.7.4.2. Over
The Counter (OTC)
14.7.7.5. Benelux
Union Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.7.5.1. Hospitals
14.7.7.5.1.1. Critical
Care Units
14.7.7.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.7.5.1.3. Others
14.7.7.5.2. Private
Clinics
14.7.7.5.3. Diagnostic
Centres
14.7.7.5.4. Home
Care Settings
14.7.7.5.5. Doctor’s
Offices
14.7.7.5.6. Ambulatory
Care Centers
14.7.7.5.7. Emergency
Departments
14.7.7.5.8. Laboratories
14.7.7.5.9. Others
14.7.7.6. Benelux
Union Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The
Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest
of Europe Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.7.8.1.1. Albumin
Analyzers (Albumin Testing)
14.7.8.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
14.7.8.1.3. Cardiac
Marker Analyzers
14.7.8.1.4. Clinical
Chemistry Analyzers
14.7.8.1.5. Coagulation
Analyzer / Microcoagulation System
14.7.8.1.6. Creatinine
Analyzer
14.7.8.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
14.7.8.1.8. Laboratory
Blood Glucose Analyzers
14.7.8.1.9. Urinalysis
Products
14.7.8.1.9.1. Analyzers
14.7.8.1.9.2. Strips
14.7.8.1.9.3. Controls
14.7.8.1.9.4. Supplies
14.7.8.1.10. Drugs-of-abuse
Testing Products
14.7.8.1.11. Fecal
Occult Testing Products
14.7.8.1.12. Hematology
Testing Products
14.7.8.1.13. HbA1c
and Diabetes Products
14.7.8.1.14. Infectious
Disease Testing Products
14.7.8.1.14.1. HIV
Infections
14.7.8.1.14.2. Malaria
14.7.8.1.14.3. Syphilis
14.7.8.1.14.4. E.Coli
14.7.8.1.14.5. Influenza
14.7.8.1.14.6. Others
14.7.8.1.15. Others
(CO-Oximeter, etc.)
14.7.8.2. Rest
of Europe Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
14.7.8.2.1. Dipstick
and Lateral Flow Configurations
14.7.8.2.2. Microfluidics
14.7.8.2.3. Magnetic
immunoassay
14.7.8.2.4. Molecular
Diagnostics
14.7.8.3. Rest
of Europe Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
14.7.8.3.1. Handheld
14.7.8.3.2. Benchtop
Models
14.7.8.4. Rest
of Europe Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
14.7.8.4.1. Prescription
Based
14.7.8.4.2. Over
The Counter (OTC)
14.7.8.5. Rest
of Europe Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.8.5.1. Hospitals
14.7.8.5.1.1. Critical
Care Units
14.7.8.5.1.2. Neonatal
Intensive Care Unit (NICU)
14.7.8.5.1.3. Others
14.7.8.5.2. Private
Clinics
14.7.8.5.3. Diagnostic
Centres
14.7.8.5.4. Home
Care Settings
14.7.8.5.5. Doctor’s
Offices
14.7.8.5.6. Ambulatory
Care Centers
14.7.8.5.7. Emergency
Departments
14.7.8.5.8. Laboratories
14.7.8.5.9. Others
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By
Product Type
14.8.3. By
Formats
14.8.4. By
Device Type
14.8.5. By Type
14.8.6. By End
Users
15. Asia Pacific Point of Care (POC) Diagnostic Devices Market
Analysis and Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Asia
Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
15.2. Asia
Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.2.1. Albumin
Analyzers (Albumin Testing)
15.2.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.2.3. Cardiac
Marker Analyzers
15.2.4. Clinical
Chemistry Analyzers
15.2.5. Coagulation
Analyzer / Microcoagulation System
15.2.6. Creatinine
Analyzer
15.2.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.2.8. Laboratory
Blood Glucose Analyzers
15.2.9. Urinalysis
Products
15.2.9.1. Analyzers
15.2.9.2. Strips
15.2.9.3. Controls
15.2.9.4. Supplies
15.2.10. Drugs-of-abuse
Testing Products
15.2.11. Fecal
Occult Testing Products
15.2.12. Hematology
Testing Products
15.2.13. HbA1c
and Diabetes Products
15.2.14. Infectious
Disease Testing Products
15.2.14.1. HIV
Infections
15.2.14.2. Malaria
15.2.14.3. Syphilis
15.2.14.4. E.Coli
15.2.14.5. Influenza
15.2.14.6. Others
15.2.15. Others
(CO-Oximeter, etc.)
15.3. Asia
Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
15.3.1. Dipstick
and Lateral Flow Configurations
15.3.2. Microfluidics
15.3.3. Magnetic
immunoassay
15.3.4. Molecular
Diagnostics
15.4. Asia
Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
15.4.1. Handheld
15.4.2. Benchtop
Models
15.5. Asia
Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
15.5.1. Prescription
Based
15.5.2. Over
The Counter (OTC)
15.6. Asia
Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.1. Hospitals
15.6.1.1. Critical
Care Units
15.6.1.2. Neonatal
Intensive Care Unit (NICU)
15.6.1.3. Others
15.6.2. Private
Clinics
15.6.3. Diagnostic
Centres
15.6.4. Home
Care Settings
15.6.5. Doctor’s
Offices
15.6.6. Ambulatory
Care Centers
15.6.7. Emergency
Departments
15.6.8. Laboratories
15.6.9. Others
15.7. Asia
Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Country
15.7.1. China
15.7.1.1. China
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
15.7.1.1.1. Albumin
Analyzers (Albumin Testing)
15.7.1.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.1.1.3. Cardiac
Marker Analyzers
15.7.1.1.4. Clinical
Chemistry Analyzers
15.7.1.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.1.1.6. Creatinine
Analyzer
15.7.1.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.1.1.8. Laboratory
Blood Glucose Analyzers
15.7.1.1.9. Urinalysis
Products
15.7.1.1.9.1. Analyzers
15.7.1.1.9.2. Strips
15.7.1.1.9.3. Controls
15.7.1.1.9.4. Supplies
15.7.1.1.10. Drugs-of-abuse
Testing Products
15.7.1.1.11. Fecal
Occult Testing Products
15.7.1.1.12. Hematology
Testing Products
15.7.1.1.13. HbA1c
and Diabetes Products
15.7.1.1.14. Infectious
Disease Testing Products
15.7.1.1.14.1. HIV
Infections
15.7.1.1.14.2. Malaria
15.7.1.1.14.3. Syphilis
15.7.1.1.14.4. E.Coli
15.7.1.1.14.5. Influenza
15.7.1.1.14.6. Others
15.7.1.1.15. Others
(CO-Oximeter, etc.)
15.7.1.2. China
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
15.7.1.2.1. Dipstick
and Lateral Flow Configurations
15.7.1.2.2. Microfluidics
15.7.1.2.3. Magnetic
immunoassay
15.7.1.2.4. Molecular
Diagnostics
15.7.1.3. China
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
15.7.1.3.1. Handheld
15.7.1.3.2. Benchtop
Models
15.7.1.4. China
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
15.7.1.4.1. Prescription
Based
15.7.1.4.2. Over
The Counter (OTC)
15.7.1.5. China
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.1.5.1. Hospitals
15.7.1.5.1.1. Critical
Care Units
15.7.1.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.1.5.1.3. Others
15.7.1.5.2. Private
Clinics
15.7.1.5.3. Diagnostic
Centres
15.7.1.5.4. Home
Care Settings
15.7.1.5.5. Doctor’s
Offices
15.7.1.5.6. Ambulatory
Care Centers
15.7.1.5.7. Emergency
Departments
15.7.1.5.8. Laboratories
15.7.1.5.9. Others
15.7.2. Japan
15.7.2.1. Japan
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
15.7.2.1.1. Albumin
Analyzers (Albumin Testing)
15.7.2.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.2.1.3. Cardiac
Marker Analyzers
15.7.2.1.4. Clinical
Chemistry Analyzers
15.7.2.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.2.1.6. Creatinine
Analyzer
15.7.2.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.2.1.8. Laboratory
Blood Glucose Analyzers
15.7.2.1.9. Urinalysis
Products
15.7.2.1.9.1. Analyzers
15.7.2.1.9.2. Strips
15.7.2.1.9.3. Controls
15.7.2.1.9.4. Supplies
15.7.2.1.10. Drugs-of-abuse
Testing Products
15.7.2.1.11. Fecal
Occult Testing Products
15.7.2.1.12. Hematology
Testing Products
15.7.2.1.13. HbA1c
and Diabetes Products
15.7.2.1.14. Infectious
Disease Testing Products
15.7.2.1.14.1. HIV
Infections
15.7.2.1.14.2. Malaria
15.7.2.1.14.3. Syphilis
15.7.2.1.14.4. E.Coli
15.7.2.1.14.5. Influenza
15.7.2.1.14.6. Others
15.7.2.1.15. Others
(CO-Oximeter, etc.)
15.7.2.2. Japan
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
15.7.2.2.1. Dipstick
and Lateral Flow Configurations
15.7.2.2.2. Microfluidics
15.7.2.2.3. Magnetic
immunoassay
15.7.2.2.4. Molecular
Diagnostics
15.7.2.3. Japan
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
15.7.2.3.1. Handheld
15.7.2.3.2. Benchtop
Models
15.7.2.4. Japan
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
15.7.2.4.1. Prescription
Based
15.7.2.4.2. Over
The Counter (OTC)
15.7.2.5. Japan
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.2.5.1. Hospitals
15.7.2.5.1.1. Critical
Care Units
15.7.2.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.2.5.1.3. Others
15.7.2.5.2. Private
Clinics
15.7.2.5.3. Diagnostic
Centres
15.7.2.5.4. Home
Care Settings
15.7.2.5.5. Doctor’s
Offices
15.7.2.5.6. Ambulatory
Care Centers
15.7.2.5.7. Emergency
Departments
15.7.2.5.8. Laboratories
15.7.2.5.9. Others
15.7.3. India
15.7.3.1. India
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
15.7.3.1.1. Albumin
Analyzers (Albumin Testing)
15.7.3.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.3.1.3. Cardiac
Marker Analyzers
15.7.3.1.4. Clinical
Chemistry Analyzers
15.7.3.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.3.1.6. Creatinine
Analyzer
15.7.3.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.3.1.8. Laboratory
Blood Glucose Analyzers
15.7.3.1.9. Urinalysis
Products
15.7.3.1.9.1. Analyzers
15.7.3.1.9.2. Strips
15.7.3.1.9.3. Controls
15.7.3.1.9.4. Supplies
15.7.3.1.10. Drugs-of-abuse
Testing Products
15.7.3.1.11. Fecal
Occult Testing Products
15.7.3.1.12. Hematology
Testing Products
15.7.3.1.13. HbA1c
and Diabetes Products
15.7.3.1.14. Infectious
Disease Testing Products
15.7.3.1.14.1. HIV
Infections
15.7.3.1.14.2. Malaria
15.7.3.1.14.3. Syphilis
15.7.3.1.14.4. E.Coli
15.7.3.1.14.5. Influenza
15.7.3.1.14.6. Others
15.7.3.1.15. Others
(CO-Oximeter, etc.)
15.7.3.2. India
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
15.7.3.2.1. Dipstick
and Lateral Flow Configurations
15.7.3.2.2. Microfluidics
15.7.3.2.3. Magnetic
immunoassay
15.7.3.2.4. Molecular
Diagnostics
15.7.3.3. India
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
15.7.3.3.1. Handheld
15.7.3.3.2. Benchtop
Models
15.7.3.4. India
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
15.7.3.4.1. Prescription
Based
15.7.3.4.2. Over
The Counter (OTC)
15.7.3.5. India
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.3.5.1. Hospitals
15.7.3.5.1.1. Critical
Care Units
15.7.3.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.3.5.1.3. Others
15.7.3.5.2. Private
Clinics
15.7.3.5.3. Diagnostic
Centres
15.7.3.5.4. Home
Care Settings
15.7.3.5.5. Doctor’s
Offices
15.7.3.5.6. Ambulatory
Care Centers
15.7.3.5.7. Emergency
Departments
15.7.3.5.8. Laboratories
15.7.3.5.9. Others
15.7.4. New
Zealand
15.7.4.1. New
Zealand Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
15.7.4.1.1. Albumin
Analyzers (Albumin Testing)
15.7.4.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.4.1.3. Cardiac
Marker Analyzers
15.7.4.1.4. Clinical
Chemistry Analyzers
15.7.4.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.4.1.6. Creatinine
Analyzer
15.7.4.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.4.1.8. Laboratory
Blood Glucose Analyzers
15.7.4.1.9. Urinalysis
Products
15.7.4.1.9.1. Analyzers
15.7.4.1.9.2. Strips
15.7.4.1.9.3. Controls
15.7.4.1.9.4. Supplies
15.7.4.1.10. Drugs-of-abuse
Testing Products
15.7.4.1.11. Fecal
Occult Testing Products
15.7.4.1.12. Hematology
Testing Products
15.7.4.1.13. HbA1c
and Diabetes Products
15.7.4.1.14. Infectious
Disease Testing Products
15.7.4.1.14.1. HIV
Infections
15.7.4.1.14.2. Malaria
15.7.4.1.14.3. Syphilis
15.7.4.1.14.4. E.Coli
15.7.4.1.14.5. Influenza
15.7.4.1.14.6. Others
15.7.4.1.15. Others
(CO-Oximeter, etc.)
15.7.4.2. New
Zealand Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
15.7.4.2.1. Dipstick
and Lateral Flow Configurations
15.7.4.2.2. Microfluidics
15.7.4.2.3. Magnetic
immunoassay
15.7.4.2.4. Molecular
Diagnostics
15.7.4.3. New
Zealand Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
15.7.4.3.1. Handheld
15.7.4.3.2. Benchtop
Models
15.7.4.4. New
Zealand Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
15.7.4.4.1. Prescription
Based
15.7.4.4.2. Over
The Counter (OTC)
15.7.4.5. New
Zealand Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.4.5.1. Hospitals
15.7.4.5.1.1. Critical
Care Units
15.7.4.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.4.5.1.3. Others
15.7.4.5.2. Private
Clinics
15.7.4.5.3. Diagnostic
Centres
15.7.4.5.4. Home
Care Settings
15.7.4.5.5. Doctor’s
Offices
15.7.4.5.6. Ambulatory
Care Centers
15.7.4.5.7. Emergency
Departments
15.7.4.5.8. Laboratories
15.7.4.5.9. Others
15.7.5. Australia
15.7.5.1. Australia
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
15.7.5.1.1. Albumin
Analyzers (Albumin Testing)
15.7.5.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.5.1.3. Cardiac
Marker Analyzers
15.7.5.1.4. Clinical
Chemistry Analyzers
15.7.5.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.5.1.6. Creatinine
Analyzer
15.7.5.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.5.1.8. Laboratory
Blood Glucose Analyzers
15.7.5.1.9. Urinalysis
Products
15.7.5.1.9.1. Analyzers
15.7.5.1.9.2. Strips
15.7.5.1.9.3. Controls
15.7.5.1.9.4. Supplies
15.7.5.1.10. Drugs-of-abuse
Testing Products
15.7.5.1.11. Fecal
Occult Testing Products
15.7.5.1.12. Hematology
Testing Products
15.7.5.1.13. HbA1c
and Diabetes Products
15.7.5.1.14. Infectious
Disease Testing Products
15.7.5.1.14.1. HIV
Infections
15.7.5.1.14.2. Malaria
15.7.5.1.14.3. Syphilis
15.7.5.1.14.4. E.Coli
15.7.5.1.14.5. Influenza
15.7.5.1.14.6. Others
15.7.5.1.15. Others
(CO-Oximeter, etc.)
15.7.5.2. Australia
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
15.7.5.2.1. Dipstick
and Lateral Flow Configurations
15.7.5.2.2. Microfluidics
15.7.5.2.3. Magnetic
immunoassay
15.7.5.2.4. Molecular
Diagnostics
15.7.5.3. Australia
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
15.7.5.3.1. Handheld
15.7.5.3.2. Benchtop
Models
15.7.5.4. Australia
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
15.7.5.4.1. Prescription
Based
15.7.5.4.2. Over
The Counter (OTC)
15.7.5.5. Australia
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.5.5.1. Hospitals
15.7.5.5.1.1. Critical
Care Units
15.7.5.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.5.5.1.3. Others
15.7.5.5.2. Private
Clinics
15.7.5.5.3. Diagnostic
Centres
15.7.5.5.4. Home
Care Settings
15.7.5.5.5. Doctor’s
Offices
15.7.5.5.6. Ambulatory
Care Centers
15.7.5.5.7. Emergency
Departments
15.7.5.5.8. Laboratories
15.7.5.5.9. Others
15.7.6. South
Korea
15.7.6.1. South
Korea Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.7.6.1.1. Albumin
Analyzers (Albumin Testing)
15.7.6.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.6.1.3. Cardiac
Marker Analyzers
15.7.6.1.4. Clinical
Chemistry Analyzers
15.7.6.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.6.1.6. Creatinine
Analyzer
15.7.6.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.6.1.8. Laboratory
Blood Glucose Analyzers
15.7.6.1.9. Urinalysis
Products
15.7.6.1.9.1. Analyzers
15.7.6.1.9.2. Strips
15.7.6.1.9.3. Controls
15.7.6.1.9.4. Supplies
15.7.6.1.10. Drugs-of-abuse
Testing Products
15.7.6.1.11. Fecal
Occult Testing Products
15.7.6.1.12. Hematology
Testing Products
15.7.6.1.13. HbA1c
and Diabetes Products
15.7.6.1.14. Infectious
Disease Testing Products
15.7.6.1.14.1. HIV
Infections
15.7.6.1.14.2. Malaria
15.7.6.1.14.3. Syphilis
15.7.6.1.14.4. E.Coli
15.7.6.1.14.5. Influenza
15.7.6.1.14.6. Others
15.7.6.1.15. Others
(CO-Oximeter, etc.)
15.7.6.2. South
Korea Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
15.7.6.2.1. Dipstick
and Lateral Flow Configurations
15.7.6.2.2. Microfluidics
15.7.6.2.3. Magnetic
immunoassay
15.7.6.2.4. Molecular
Diagnostics
15.7.6.3. South
Korea Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
15.7.6.3.1. Handheld
15.7.6.3.2. Benchtop
Models
15.7.6.4. South
Korea Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
15.7.6.4.1. Prescription
Based
15.7.6.4.2. Over
The Counter (OTC)
15.7.6.5. South
Korea Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.6.5.1. Hospitals
15.7.6.5.1.1. Critical
Care Units
15.7.6.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.6.5.1.3. Others
15.7.6.5.2. Private
Clinics
15.7.6.5.3. Diagnostic
Centres
15.7.6.5.4. Home
Care Settings
15.7.6.5.5. Doctor’s
Offices
15.7.6.5.6. Ambulatory
Care Centers
15.7.6.5.7. Emergency
Departments
15.7.6.5.8. Laboratories
15.7.6.5.9. Others
15.7.7. Southeast
Asia
15.7.7.1. Southeast
Asia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.7.7.1.1. Albumin
Analyzers (Albumin Testing)
15.7.7.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.7.1.3. Cardiac
Marker Analyzers
15.7.7.1.4. Clinical
Chemistry Analyzers
15.7.7.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.7.1.6. Creatinine
Analyzer
15.7.7.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.7.1.8. Laboratory
Blood Glucose Analyzers
15.7.7.1.9. Urinalysis
Products
15.7.7.1.9.1. Analyzers
15.7.7.1.9.2. Strips
15.7.7.1.9.3. Controls
15.7.7.1.9.4. Supplies
15.7.7.1.10. Drugs-of-abuse
Testing Products
15.7.7.1.11. Fecal
Occult Testing Products
15.7.7.1.12. Hematology
Testing Products
15.7.7.1.13. HbA1c
and Diabetes Products
15.7.7.1.14. Infectious
Disease Testing Products
15.7.7.1.14.1. HIV
Infections
15.7.7.1.14.2. Malaria
15.7.7.1.14.3. Syphilis
15.7.7.1.14.4. E.Coli
15.7.7.1.14.5. Influenza
15.7.7.1.14.6. Others
15.7.7.1.15. Others
(CO-Oximeter, etc.)
15.7.7.2. Southeast
Asia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
15.7.7.2.1. Dipstick
and Lateral Flow Configurations
15.7.7.2.2. Microfluidics
15.7.7.2.3. Magnetic
immunoassay
15.7.7.2.4. Molecular
Diagnostics
15.7.7.3. Southeast
Asia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
15.7.7.3.1. Handheld
15.7.7.3.2. Benchtop
Models
15.7.7.4. Southeast
Asia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
15.7.7.4.1. Prescription
Based
15.7.7.4.2. Over
The Counter (OTC)
15.7.7.5. Southeast
Asia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.7.5.1. Hospitals
15.7.7.5.1.1. Critical
Care Units
15.7.7.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.7.5.1.3. Others
15.7.7.5.2. Private
Clinics
15.7.7.5.3. Diagnostic
Centres
15.7.7.5.4. Home
Care Settings
15.7.7.5.5. Doctor’s
Offices
15.7.7.5.6. Ambulatory
Care Centers
15.7.7.5.7. Emergency
Departments
15.7.7.5.8. Laboratories
15.7.7.5.9. Others
15.7.7.6. Southeast
Asia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest
of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest
of Asia Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Product Type
15.7.8.1.1. Albumin
Analyzers (Albumin Testing)
15.7.8.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
15.7.8.1.3. Cardiac
Marker Analyzers
15.7.8.1.4. Clinical
Chemistry Analyzers
15.7.8.1.5. Coagulation
Analyzer / Microcoagulation System
15.7.8.1.6. Creatinine
Analyzer
15.7.8.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
15.7.8.1.8. Laboratory
Blood Glucose Analyzers
15.7.8.1.9. Urinalysis
Products
15.7.8.1.9.1. Analyzers
15.7.8.1.9.2. Strips
15.7.8.1.9.3. Controls
15.7.8.1.9.4. Supplies
15.7.8.1.10. Drugs-of-abuse
Testing Products
15.7.8.1.11. Fecal
Occult Testing Products
15.7.8.1.12. Hematology
Testing Products
15.7.8.1.13. HbA1c
and Diabetes Products
15.7.8.1.14. Infectious
Disease Testing Products
15.7.8.1.14.1. HIV
Infections
15.7.8.1.14.2. Malaria
15.7.8.1.14.3. Syphilis
15.7.8.1.14.4. E.Coli
15.7.8.1.14.5. Influenza
15.7.8.1.14.6. Others
15.7.8.1.15. Others
(CO-Oximeter, etc.)
15.7.8.2. Rest
of Asia Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Formats
15.7.8.2.1. Dipstick
and Lateral Flow Configurations
15.7.8.2.2. Microfluidics
15.7.8.2.3. Magnetic
immunoassay
15.7.8.2.4. Molecular
Diagnostics
15.7.8.3. Rest
of Asia Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Device Type
15.7.8.3.1. Handheld
15.7.8.3.2. Benchtop
Models
15.7.8.4. Rest
of Asia Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Type
15.7.8.4.1. Prescription
Based
15.7.8.4.2. Over
The Counter (OTC)
15.7.8.5. Rest
of Asia Pacific Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By End Users
15.7.8.5.1. Hospitals
15.7.8.5.1.1. Critical
Care Units
15.7.8.5.1.2. Neonatal
Intensive Care Unit (NICU)
15.7.8.5.1.3. Others
15.7.8.5.2. Private
Clinics
15.7.8.5.3. Diagnostic
Centres
15.7.8.5.4. Home
Care Settings
15.7.8.5.5. Doctor’s
Offices
15.7.8.5.6. Ambulatory
Care Centers
15.7.8.5.7. Emergency
Departments
15.7.8.5.8. Laboratories
15.7.8.5.9. Others
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By
Product Type
15.8.3. By
Formats
15.8.4. By Device
Type
15.8.5. By Type
15.8.6. By End
Users
16. Middle East and Africa Point of Care (POC) Diagnostic Devices
Market Analysis and Forecasts, 2019 - 2027
16.1. Overview
16.1.1. Middle
East and Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
16.2. Middle
East and Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Product Type
16.2.1. Albumin
Analyzers (Albumin Testing)
16.2.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
16.2.3. Cardiac
Marker Analyzers
16.2.4. Clinical
Chemistry Analyzers
16.2.5. Coagulation
Analyzer / Microcoagulation System
16.2.6. Creatinine
Analyzer
16.2.7. CRP
Analyzer (C-Reactive Protein Analyzers)
16.2.8. Laboratory
Blood Glucose Analyzers
16.2.9. Urinalysis
Products
16.2.9.1. Analyzers
16.2.9.2. Strips
16.2.9.3. Controls
16.2.9.4. Supplies
16.2.10. Drugs-of-abuse
Testing Products
16.2.11. Fecal
Occult Testing Products
16.2.12. Hematology
Testing Products
16.2.13. HbA1c
and Diabetes Products
16.2.14. Infectious
Disease Testing Products
16.2.14.1. HIV
Infections
16.2.14.2. Malaria
16.2.14.3. Syphilis
16.2.14.4. E.Coli
16.2.14.5. Influenza
16.2.14.6. Others
16.2.15. Others
(CO-Oximeter, etc.)
16.3. Middle
East and Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Formats
16.3.1. Dipstick
and Lateral Flow Configurations
16.3.2. Microfluidics
16.3.3. Magnetic
immunoassay
16.3.4. Molecular
Diagnostics
16.4. Middle
East and Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Device Type
16.4.1. Handheld
16.4.2. Benchtop
Models
16.5. Middle
East and Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Type
16.5.1. Prescription
Based
16.5.2. Over
The Counter (OTC)
16.6. Middle
East and Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By End Users
16.6.1. Hospitals
16.6.1.1. Critical
Care Units
16.6.1.2. Neonatal
Intensive Care Unit (NICU)
16.6.1.3. Others
16.6.2. Private
Clinics
16.6.3. Diagnostic
Centres
16.6.4. Home
Care Settings
16.6.5. Doctor’s
Offices
16.6.6. Ambulatory
Care Centers
16.6.7. Emergency
Departments
16.6.8. Laboratories
16.6.9. Others
16.7. Middle
East and Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi
Arabia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
16.7.1.1.1. Albumin
Analyzers (Albumin Testing)
16.7.1.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
16.7.1.1.3. Cardiac
Marker Analyzers
16.7.1.1.4. Clinical
Chemistry Analyzers
16.7.1.1.5. Coagulation
Analyzer / Microcoagulation System
16.7.1.1.6. Creatinine
Analyzer
16.7.1.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
16.7.1.1.8. Laboratory
Blood Glucose Analyzers
16.7.1.1.9. Urinalysis
Products
16.7.1.1.9.1. Analyzers
16.7.1.1.9.2. Strips
16.7.1.1.9.3. Controls
16.7.1.1.9.4. Supplies
16.7.1.1.10. Drugs-of-abuse
Testing Products
16.7.1.1.11. Fecal
Occult Testing Products
16.7.1.1.12. Hematology
Testing Products
16.7.1.1.13. HbA1c
and Diabetes Products
16.7.1.1.14. Infectious
Disease Testing Products
16.7.1.1.14.1. HIV
Infections
16.7.1.1.14.2. Malaria
16.7.1.1.14.3. Syphilis
16.7.1.1.14.4. E.Coli
16.7.1.1.14.5. Influenza
16.7.1.1.14.6. Others
16.7.1.1.15. Others
(CO-Oximeter, etc.)
16.7.1.2. Saudi
Arabia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
16.7.1.2.1. Dipstick
and Lateral Flow Configurations
16.7.1.2.2. Microfluidics
16.7.1.2.3. Magnetic
immunoassay
16.7.1.2.4. Molecular
Diagnostics
16.7.1.3. Saudi
Arabia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
16.7.1.3.1. Handheld
16.7.1.3.2. Benchtop
Models
16.7.1.4. Saudi
Arabia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
16.7.1.4.1. Prescription
Based
16.7.1.4.2. Over
The Counter (OTC)
16.7.1.5. Saudi
Arabia Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.1.5.1. Hospitals
16.7.1.5.1.1. Critical
Care Units
16.7.1.5.1.2. Neonatal
Intensive Care Unit (NICU)
16.7.1.5.1.3. Others
16.7.1.5.2. Private
Clinics
16.7.1.5.3. Diagnostic
Centres
16.7.1.5.4. Home
Care Settings
16.7.1.5.5. Doctor’s
Offices
16.7.1.5.6. Ambulatory
Care Centers
16.7.1.5.7. Emergency
Departments
16.7.1.5.8. Laboratories
16.7.1.5.9. Others
16.7.2. UAE
16.7.2.1. UAE
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
16.7.2.1.1. Albumin
Analyzers (Albumin Testing)
16.7.2.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
16.7.2.1.3. Cardiac
Marker Analyzers
16.7.2.1.4. Clinical
Chemistry Analyzers
16.7.2.1.5. Coagulation
Analyzer / Microcoagulation System
16.7.2.1.6. Creatinine
Analyzer
16.7.2.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
16.7.2.1.8. Laboratory
Blood Glucose Analyzers
16.7.2.1.9. Urinalysis
Products
16.7.2.1.9.1. Analyzers
16.7.2.1.9.2. Strips
16.7.2.1.9.3. Controls
16.7.2.1.9.4. Supplies
16.7.2.1.10. Drugs-of-abuse
Testing Products
16.7.2.1.11. Fecal
Occult Testing Products
16.7.2.1.12. Hematology
Testing Products
16.7.2.1.13. HbA1c
and Diabetes Products
16.7.2.1.14. Infectious
Disease Testing Products
16.7.2.1.14.1. HIV
Infections
16.7.2.1.14.2. Malaria
16.7.2.1.14.3. Syphilis
16.7.2.1.14.4. E.Coli
16.7.2.1.14.5. Influenza
16.7.2.1.14.6. Others
16.7.2.1.15. Others
(CO-Oximeter, etc.)
16.7.2.2. UAE
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
16.7.2.2.1. Dipstick
and Lateral Flow Configurations
16.7.2.2.2. Microfluidics
16.7.2.2.3. Magnetic
immunoassay
16.7.2.2.4. Molecular
Diagnostics
16.7.2.3. UAE
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
16.7.2.3.1. Handheld
16.7.2.3.2. Benchtop
Models
16.7.2.4. UAE
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
16.7.2.4.1. Prescription
Based
16.7.2.4.2. Over
The Counter (OTC)
16.7.2.5. UAE
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
16.7.2.5.1. Hospitals
16.7.2.5.1.1. Critical
Care Units
16.7.2.5.1.2. Neonatal
Intensive Care Unit (NICU)
16.7.2.5.1.3. Others
16.7.2.5.2. Private
Clinics
16.7.2.5.3. Diagnostic
Centres
16.7.2.5.4. Home
Care Settings
16.7.2.5.5. Doctor’s
Offices
16.7.2.5.6. Ambulatory
Care Centers
16.7.2.5.7. Emergency
Departments
16.7.2.5.8. Laboratories
16.7.2.5.9. Others
16.7.3. Egypt
16.7.3.1. Egypt
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
16.7.3.1.1. Albumin
Analyzers (Albumin Testing)
16.7.3.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
16.7.3.1.3. Cardiac
Marker Analyzers
16.7.3.1.4. Clinical
Chemistry Analyzers
16.7.3.1.5. Coagulation
Analyzer / Microcoagulation System
16.7.3.1.6. Creatinine
Analyzer
16.7.3.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
16.7.3.1.8. Laboratory
Blood Glucose Analyzers
16.7.3.1.9. Urinalysis
Products
16.7.3.1.9.1. Analyzers
16.7.3.1.9.2. Strips
16.7.3.1.9.3. Controls
16.7.3.1.9.4. Supplies
16.7.3.1.10. Drugs-of-abuse
Testing Products
16.7.3.1.11. Fecal
Occult Testing Products
16.7.3.1.12. Hematology
Testing Products
16.7.3.1.13. HbA1c
and Diabetes Products
16.7.3.1.14. Infectious
Disease Testing Products
16.7.3.1.14.1. HIV
Infections
16.7.3.1.14.2. Malaria
16.7.3.1.14.3. Syphilis
16.7.3.1.14.4. E.Coli
16.7.3.1.14.5. Influenza
16.7.3.1.14.6. Others
16.7.3.1.15. Others
(CO-Oximeter, etc.)
16.7.3.2. Egypt
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
16.7.3.2.1. Dipstick
and Lateral Flow Configurations
16.7.3.2.2. Microfluidics
16.7.3.2.3. Magnetic
immunoassay
16.7.3.2.4. Molecular
Diagnostics
16.7.3.3. Egypt
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
16.7.3.3.1. Handheld
16.7.3.3.2. Benchtop
Models
16.7.3.4. Egypt
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
16.7.3.4.1. Prescription
Based
16.7.3.4.2. Over
The Counter (OTC)
16.7.3.5. Egypt
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
16.7.3.5.1. Hospitals
16.7.3.5.1.1. Critical
Care Units
16.7.3.5.1.2. Neonatal
Intensive Care Unit (NICU)
16.7.3.5.1.3. Others
16.7.3.5.2. Private
Clinics
16.7.3.5.3. Diagnostic
Centres
16.7.3.5.4. Home
Care Settings
16.7.3.5.5. Doctor’s
Offices
16.7.3.5.6. Ambulatory
Care Centers
16.7.3.5.7. Emergency
Departments
16.7.3.5.8. Laboratories
16.7.3.5.9. Others
16.7.4. Kuwait
16.7.4.1. Kuwait
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
16.7.4.1.1. Albumin
Analyzers (Albumin Testing)
16.7.4.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
16.7.4.1.3. Cardiac
Marker Analyzers
16.7.4.1.4. Clinical
Chemistry Analyzers
16.7.4.1.5. Coagulation
Analyzer / Microcoagulation System
16.7.4.1.6. Creatinine
Analyzer
16.7.4.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
16.7.4.1.8. Laboratory
Blood Glucose Analyzers
16.7.4.1.9. Urinalysis
Products
16.7.4.1.9.1. Analyzers
16.7.4.1.9.2. Strips
16.7.4.1.9.3. Controls
16.7.4.1.9.4. Supplies
16.7.4.1.10. Drugs-of-abuse
Testing Products
16.7.4.1.11. Fecal
Occult Testing Products
16.7.4.1.12. Hematology
Testing Products
16.7.4.1.13. HbA1c
and Diabetes Products
16.7.4.1.14. Infectious
Disease Testing Products
16.7.4.1.14.1. HIV
Infections
16.7.4.1.14.2. Malaria
16.7.4.1.14.3. Syphilis
16.7.4.1.14.4. E.Coli
16.7.4.1.14.5. Influenza
16.7.4.1.14.6. Others
16.7.4.1.15. Others
(CO-Oximeter, etc.)
16.7.4.2. Kuwait
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
16.7.4.2.1. Dipstick
and Lateral Flow Configurations
16.7.4.2.2. Microfluidics
16.7.4.2.3. Magnetic
immunoassay
16.7.4.2.4. Molecular
Diagnostics
16.7.4.3. Kuwait
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
16.7.4.3.1. Handheld
16.7.4.3.2. Benchtop
Models
16.7.4.4. Kuwait
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
16.7.4.4.1. Prescription
Based
16.7.4.4.2. Over
The Counter (OTC)
16.7.4.5. Kuwait
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
16.7.4.5.1. Hospitals
16.7.4.5.1.1. Critical
Care Units
16.7.4.5.1.2. Neonatal
Intensive Care Unit (NICU)
16.7.4.5.1.3. Others
16.7.4.5.2. Private
Clinics
16.7.4.5.3. Diagnostic
Centres
16.7.4.5.4. Home
Care Settings
16.7.4.5.5. Doctor’s
Offices
16.7.4.5.6. Ambulatory
Care Centers
16.7.4.5.7. Emergency
Departments
16.7.4.5.8. Laboratories
16.7.4.5.9. Others
16.7.5. South
Africa
16.7.5.1. South
Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
16.7.5.1.1. Albumin
Analyzers (Albumin Testing)
16.7.5.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
16.7.5.1.3. Cardiac
Marker Analyzers
16.7.5.1.4. Clinical
Chemistry Analyzers
16.7.5.1.5. Coagulation
Analyzer / Microcoagulation System
16.7.5.1.6. Creatinine
Analyzer
16.7.5.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
16.7.5.1.8. Laboratory
Blood Glucose Analyzers
16.7.5.1.9. Urinalysis
Products
16.7.5.1.9.1. Analyzers
16.7.5.1.9.2. Strips
16.7.5.1.9.3. Controls
16.7.5.1.9.4. Supplies
16.7.5.1.10. Drugs-of-abuse
Testing Products
16.7.5.1.11. Fecal
Occult Testing Products
16.7.5.1.12. Hematology
Testing Products
16.7.5.1.13. HbA1c
and Diabetes Products
16.7.5.1.14. Infectious
Disease Testing Products
16.7.5.1.14.1. HIV
Infections
16.7.5.1.14.2. Malaria
16.7.5.1.14.3. Syphilis
16.7.5.1.14.4. E.Coli
16.7.5.1.14.5. Influenza
16.7.5.1.14.6. Others
16.7.5.1.15. Others
(CO-Oximeter, etc.)
16.7.5.2. South
Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
16.7.5.2.1. Dipstick
and Lateral Flow Configurations
16.7.5.2.2. Microfluidics
16.7.5.2.3. Magnetic
immunoassay
16.7.5.2.4. Molecular
Diagnostics
16.7.5.3. South
Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
16.7.5.3.1. Handheld
16.7.5.3.2. Benchtop
Models
16.7.5.4. South
Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
16.7.5.4.1. Prescription
Based
16.7.5.4.2. Over
The Counter (OTC)
16.7.5.5. South
Africa Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.5.5.1. Hospitals
16.7.5.5.1.1. Critical
Care Units
16.7.5.5.1.2. Neonatal
Intensive Care Unit (NICU)
16.7.5.5.1.3. Others
16.7.5.5.2. Private
Clinics
16.7.5.5.3. Diagnostic
Centres
16.7.5.5.4. Home
Care Settings
16.7.5.5.5. Doctor’s
Offices
16.7.5.5.6. Ambulatory
Care Centers
16.7.5.5.7. Emergency
Departments
16.7.5.5.8. Laboratories
16.7.5.5.9. Others
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest
of Middle East & Africa Point of Care (POC) Diagnostic Devices Market
Revenue (US$ Mn) and Forecasts, By Product Type
16.7.6.1.1. Albumin
Analyzers (Albumin Testing)
16.7.6.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
16.7.6.1.3. Cardiac
Marker Analyzers
16.7.6.1.4. Clinical
Chemistry Analyzers
16.7.6.1.5. Coagulation
Analyzer / Microcoagulation System
16.7.6.1.6. Creatinine
Analyzer
16.7.6.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
16.7.6.1.8. Laboratory
Blood Glucose Analyzers
16.7.6.1.9. Urinalysis
Products
16.7.6.1.9.1. Analyzers
16.7.6.1.9.2. Strips
16.7.6.1.9.3. Controls
16.7.6.1.9.4. Supplies
16.7.6.1.10. Drugs-of-abuse
Testing Products
16.7.6.1.11. Fecal
Occult Testing Products
16.7.6.1.12. Hematology
Testing Products
16.7.6.1.13. HbA1c
and Diabetes Products
16.7.6.1.14. Infectious
Disease Testing Products
16.7.6.1.14.1. HIV
Infections
16.7.6.1.14.2. Malaria
16.7.6.1.14.3. Syphilis
16.7.6.1.14.4. E.Coli
16.7.6.1.14.5. Influenza
16.7.6.1.14.6. Others
16.7.6.1.15. Others
(CO-Oximeter, etc.)
16.7.6.2. Rest
of Middle East & Africa Point of Care (POC) Diagnostic Devices Market
Revenue (US$ Mn) and Forecasts, By Formats
16.7.6.2.1. Dipstick
and Lateral Flow Configurations
16.7.6.2.2. Microfluidics
16.7.6.2.3. Magnetic
immunoassay
16.7.6.2.4. Molecular
Diagnostics
16.7.6.3. Rest
of Middle East & Africa Point of Care (POC) Diagnostic Devices Market
Revenue (US$ Mn) and Forecasts, By Device Type
16.7.6.3.1. Handheld
16.7.6.3.2. Benchtop
Models
16.7.6.4. Rest
of Middle East & Africa Point of Care (POC) Diagnostic Devices Market
Revenue (US$ Mn) and Forecasts, By Type
16.7.6.4.1. Prescription
Based
16.7.6.4.2. Over
The Counter (OTC)
16.7.6.5. Rest
of Middle East & Africa Point of Care (POC) Diagnostic Devices Market
Revenue (US$ Mn) and Forecasts, By End Users
16.7.6.5.1. Hospitals
16.7.6.5.1.1. Critical
Care Units
16.7.6.5.1.2. Neonatal
Intensive Care Unit (NICU)
16.7.6.5.1.3. Others
16.7.6.5.2. Private
Clinics
16.7.6.5.3. Diagnostic
Centres
16.7.6.5.4. Home
Care Settings
16.7.6.5.5. Doctor’s
Offices
16.7.6.5.6. Ambulatory
Care Centers
16.7.6.5.7. Emergency
Departments
16.7.6.5.8. Laboratories
16.7.6.5.9. Others
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Product Type
16.8.3. By
Formats
16.8.4. By
Device Type
16.8.5. By Type
16.8.6. By End
Users
17. Latin America Point of Care (POC) Diagnostic Devices Market
Analysis and Forecasts, 2019 - 2027
17.1. Overview
17.1.1. Latin
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
17.2. Latin
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Product Type
17.2.1. Albumin
Analyzers (Albumin Testing)
17.2.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
17.2.3. Cardiac
Marker Analyzers
17.2.4. Clinical
Chemistry Analyzers
17.2.5. Coagulation
Analyzer / Microcoagulation System
17.2.6. Creatinine
Analyzer
17.2.7. CRP
Analyzer (C-Reactive Protein Analyzers)
17.2.8. Laboratory
Blood Glucose Analyzers
17.2.9. Urinalysis
Products
17.2.9.1. Analyzers
17.2.9.2. Strips
17.2.9.3. Controls
17.2.9.4. Supplies
17.2.10. Drugs-of-abuse
Testing Products
17.2.11. Fecal
Occult Testing Products
17.2.12. Hematology
Testing Products
17.2.13. HbA1c
and Diabetes Products
17.2.14. Infectious
Disease Testing Products
17.2.14.1. HIV
Infections
17.2.14.2. Malaria
17.2.14.3. Syphilis
17.2.14.4. E.Coli
17.2.14.5. Influenza
17.2.14.6. Others
17.2.15. Others
(CO-Oximeter, etc.)
17.3. Latin
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Formats
17.3.1. Dipstick
and Lateral Flow Configurations
17.3.2. Microfluidics
17.3.3. Magnetic
immunoassay
17.3.4. Molecular
Diagnostics
17.4. Latin
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Device Type
17.4.1. Handheld
17.4.2. Benchtop
Models
17.5. Latin
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Type
17.5.1. Prescription
Based
17.5.2. Over
The Counter (OTC)
17.6. Latin
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
17.6.1. Hospitals
17.6.1.1. Critical
Care Units
17.6.1.2. Neonatal
Intensive Care Unit (NICU)
17.6.1.3. Others
17.6.2. Private
Clinics
17.6.3. Diagnostic
Centres
17.6.4. Home
Care Settings
17.6.5. Doctor’s
Offices
17.6.6. Ambulatory
Care Centers
17.6.7. Emergency
Departments
17.6.8. Laboratories
17.6.9. Others
17.7. Latin
America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and
Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
17.7.1.1.1. Albumin
Analyzers (Albumin Testing)
17.7.1.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
17.7.1.1.3. Cardiac
Marker Analyzers
17.7.1.1.4. Clinical
Chemistry Analyzers
17.7.1.1.5. Coagulation
Analyzer / Microcoagulation System
17.7.1.1.6. Creatinine
Analyzer
17.7.1.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
17.7.1.1.8. Laboratory
Blood Glucose Analyzers
17.7.1.1.9. Urinalysis
Products
17.7.1.1.9.1. Analyzers
17.7.1.1.9.2. Strips
17.7.1.1.9.3. Controls
17.7.1.1.9.4. Supplies
17.7.1.1.10. Drugs-of-abuse
Testing Products
17.7.1.1.11. Fecal
Occult Testing Products
17.7.1.1.12. Hematology
Testing Products
17.7.1.1.13. HbA1c
and Diabetes Products
17.7.1.1.14. Infectious
Disease Testing Products
17.7.1.1.14.1. HIV
Infections
17.7.1.1.14.2. Malaria
17.7.1.1.14.3. Syphilis
17.7.1.1.14.4. E.Coli
17.7.1.1.14.5. Influenza
17.7.1.1.14.6. Others
17.7.1.1.15. Others
(CO-Oximeter, etc.)
17.7.1.2. Brazil
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
17.7.1.2.1. Dipstick
and Lateral Flow Configurations
17.7.1.2.2. Microfluidics
17.7.1.2.3. Magnetic
immunoassay
17.7.1.2.4. Molecular
Diagnostics
17.7.1.3. Brazil
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
17.7.1.3.1. Handheld
17.7.1.3.2. Benchtop
Models
17.7.1.4. Brazil
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
17.7.1.4.1. Prescription
Based
17.7.1.4.2. Over
The Counter (OTC)
17.7.1.5. Brazil
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
17.7.1.5.1. Hospitals
17.7.1.5.1.1. Critical
Care Units
17.7.1.5.1.2. Neonatal
Intensive Care Unit (NICU)
17.7.1.5.1.3. Others
17.7.1.5.2. Private
Clinics
17.7.1.5.3. Diagnostic
Centres
17.7.1.5.4. Home
Care Settings
17.7.1.5.5. Doctor’s
Offices
17.7.1.5.6. Ambulatory
Care Centers
17.7.1.5.7. Emergency
Departments
17.7.1.5.8. Laboratories
17.7.1.5.9. Others
17.7.2. Argentina
17.7.2.1. Argentina
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Product Type
17.7.2.1.1. Albumin
Analyzers (Albumin Testing)
17.7.2.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
17.7.2.1.3. Cardiac
Marker Analyzers
17.7.2.1.4. Clinical
Chemistry Analyzers
17.7.2.1.5. Coagulation
Analyzer / Microcoagulation System
17.7.2.1.6. Creatinine
Analyzer
17.7.2.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
17.7.2.1.8. Laboratory
Blood Glucose Analyzers
17.7.2.1.9. Urinalysis
Products
17.7.2.1.9.1. Analyzers
17.7.2.1.9.2. Strips
17.7.2.1.9.3. Controls
17.7.2.1.9.4. Supplies
17.7.2.1.10. Drugs-of-abuse
Testing Products
17.7.2.1.11. Fecal
Occult Testing Products
17.7.2.1.12. Hematology
Testing Products
17.7.2.1.13. HbA1c
and Diabetes Products
17.7.2.1.14. Infectious
Disease Testing Products
17.7.2.1.14.1. HIV
Infections
17.7.2.1.14.2. Malaria
17.7.2.1.14.3. Syphilis
17.7.2.1.14.4. E.Coli
17.7.2.1.14.5. Influenza
17.7.2.1.14.6. Others
17.7.2.1.15. Others
(CO-Oximeter, etc.)
17.7.2.2. Argentina
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Formats
17.7.2.2.1. Dipstick
and Lateral Flow Configurations
17.7.2.2.2. Microfluidics
17.7.2.2.3. Magnetic
immunoassay
17.7.2.2.4. Molecular
Diagnostics
17.7.2.3. Argentina
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Device Type
17.7.2.3.1. Handheld
17.7.2.3.2. Benchtop
Models
17.7.2.4. Argentina
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By Type
17.7.2.4.1. Prescription
Based
17.7.2.4.2. Over
The Counter (OTC)
17.7.2.5. Argentina
Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn) and Forecasts,
By End Users
17.7.2.5.1. Hospitals
17.7.2.5.1.1. Critical
Care Units
17.7.2.5.1.2. Neonatal
Intensive Care Unit (NICU)
17.7.2.5.1.3. Others
17.7.2.5.2. Private
Clinics
17.7.2.5.3. Diagnostic
Centres
17.7.2.5.4. Home
Care Settings
17.7.2.5.5. Doctor’s
Offices
17.7.2.5.6. Ambulatory
Care Centers
17.7.2.5.7. Emergency
Departments
17.7.2.5.8. Laboratories
17.7.2.5.9. Others
17.7.3. Rest of
Latin America
17.7.3.1. Rest
of Latin America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Product Type
17.7.3.1.1. Albumin
Analyzers (Albumin Testing)
17.7.3.1.2. Blood
Lactate Analyzer / Blood Lactate Testing Equipment
17.7.3.1.3. Cardiac
Marker Analyzers
17.7.3.1.4. Clinical
Chemistry Analyzers
17.7.3.1.5. Coagulation
Analyzer / Microcoagulation System
17.7.3.1.6. Creatinine
Analyzer
17.7.3.1.7. CRP
Analyzer (C-Reactive Protein Analyzers)
17.7.3.1.8. Laboratory
Blood Glucose Analyzers
17.7.3.1.9. Urinalysis
Products
17.7.3.1.9.1. Analyzers
17.7.3.1.9.2. Strips
17.7.3.1.9.3. Controls
17.7.3.1.9.4. Supplies
17.7.3.1.10. Drugs-of-abuse
Testing Products
17.7.3.1.11. Fecal
Occult Testing Products
17.7.3.1.12. Hematology
Testing Products
17.7.3.1.13. HbA1c
and Diabetes Products
17.7.3.1.14. Infectious
Disease Testing Products
17.7.3.1.14.1. HIV
Infections
17.7.3.1.14.2. Malaria
17.7.3.1.14.3. Syphilis
17.7.3.1.14.4. E.Coli
17.7.3.1.14.5. Influenza
17.7.3.1.14.6. Others
17.7.3.1.15. Others
(CO-Oximeter, etc.)
17.7.3.2. Rest
of Latin America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Formats
17.7.3.2.1. Dipstick
and Lateral Flow Configurations
17.7.3.2.2. Microfluidics
17.7.3.2.3. Magnetic
immunoassay
17.7.3.2.4. Molecular
Diagnostics
17.7.3.3. Rest
of Latin America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Device Type
17.7.3.3.1. Handheld
17.7.3.3.2. Benchtop
Models
17.7.3.4. Rest
of Latin America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By Type
17.7.3.4.1. Prescription
Based
17.7.3.4.2. Over
The Counter (OTC)
17.7.3.5. Rest
of Latin America Point of Care (POC) Diagnostic Devices Market Revenue (US$ Mn)
and Forecasts, By End Users
17.7.3.5.1. Hospitals
17.7.3.5.1.1. Critical
Care Units
17.7.3.5.1.2. Neonatal
Intensive Care Unit (NICU)
17.7.3.5.1.3. Others
17.7.3.5.2. Private
Clinics
17.7.3.5.3. Diagnostic
Centres
17.7.3.5.4. Home
Care Settings
17.7.3.5.5. Doctor’s
Offices
17.7.3.5.6. Ambulatory
Care Centers
17.7.3.5.7. Emergency
Departments
17.7.3.5.8. Laboratories
17.7.3.5.9. Others
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Product Type
17.8.3. By
Formats
17.8.4. By
Device Type
17.8.5. By Type
17.8.6. By End
Users
18. Competitive Benchmarking
18.1. Market
Share Analysis, 2018
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers
and Acquisitions
18.2.2. Product
Launches
18.2.3. Investments
Trends
18.2.4. R&D
Initiatives
19. Player Profiles
19.1. Abbott
Point of Care Inc.
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Becton
Dickinson and Company
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. bioMérieux
SA
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT Analysis
19.3.7. Business
Strategies
19.4. Bio-Rad
Laboratories, Inc.
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Danaher
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. DIADAMA
MEDICAL SL
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. F.
Hoffmann-La Roche Ltd
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Johnson
& Johnson Services, Inc.
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. Nova
Biomedical
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. Siemens
Healthcare Limited
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Sysmex
Corporation
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT
Analysis
19.11.7. Business
Strategies
19.12. Other
Industry Participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
